CA2622441A1 - Proteinaceous pharmaceuticals and uses thereof - Google Patents

Info

Publication number

CA2622441A1

CA2622441A1 CA002622441A CA2622441A CA2622441A1 CA 2622441 A1 CA2622441 A1 CA 2622441A1 CA 002622441 A CA002622441 A CA 002622441A CA 2622441 A CA2622441 A CA 2622441A CA 2622441 A1 CA2622441 A1 CA 2622441A1

Authority

CA

Canada

Prior art keywords

protein

proteins

naturally occurring

scaffold

cysteine

Prior art date

2005-09-27

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000003814 drug Substances 0.000 title description 26
• 108090000623 proteins and genes Proteins 0.000 claims abstract description 605
• 102000004169 proteins and genes Human genes 0.000 claims abstract description 584
• 235000018102 proteins Nutrition 0.000 claims abstract description 555
• 235000018417 cysteine Nutrition 0.000 claims abstract description 301
• 230000027455 binding Effects 0.000 claims abstract description 177
• XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims abstract description 163
• 238000000034 method Methods 0.000 claims abstract description 101
• 230000001747 exhibiting effect Effects 0.000 claims abstract description 11
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
• 235000001014 amino acid Nutrition 0.000 claims description 188
• 150000001413 amino acids Chemical class 0.000 claims description 154
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 110
• 150000002019 disulfides Chemical class 0.000 claims description 96
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 80
• -1 aliphatic amino acids Chemical class 0.000 claims description 64
• 229920001184 polypeptide Polymers 0.000 claims description 47
• 210000004027 cell Anatomy 0.000 claims description 32
• 230000002068 genetic effect Effects 0.000 claims description 25
• 230000015572 biosynthetic process Effects 0.000 claims description 23
• 230000000694 effects Effects 0.000 claims description 18
• 210000002966 serum Anatomy 0.000 claims description 17
• 230000003993 interaction Effects 0.000 claims description 16
• 239000002609 medium Substances 0.000 claims description 14
• 102000039446 nucleic acids Human genes 0.000 claims description 7
• 108020004707 nucleic acids Proteins 0.000 claims description 7
• 150000007523 nucleic acids Chemical class 0.000 claims description 7
• 108010071390 Serum Albumin Proteins 0.000 claims description 6
• 102000007562 Serum Albumin Human genes 0.000 claims description 6
• 239000000178 monomer Substances 0.000 claims description 6
• 239000003937 drug carrier Substances 0.000 claims description 5
• 210000003743 erythrocyte Anatomy 0.000 claims description 5
• 239000012636 effector Substances 0.000 claims description 3
• 150000001945 cysteines Chemical class 0.000 claims 10
• 241000724791 Filamentous phage Species 0.000 claims 1
• 238000012258 culturing Methods 0.000 claims 1
• 239000001963 growth medium Substances 0.000 claims 1
• 238000012216 screening Methods 0.000 abstract description 24
• 239000013604 expression vector Substances 0.000 abstract description 2
• 229940024606 amino acid Drugs 0.000 description 171
• 125000000151 cysteine group Chemical class N[C@@H](CS)C(=O)* 0.000 description 165
• XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 133
• 238000013459 approach Methods 0.000 description 129
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 62
• 239000000203 mixture Substances 0.000 description 62
• 108020004705 Codon Proteins 0.000 description 56
• 102000035195 Peptidases Human genes 0.000 description 56
• 108091005804 Peptidases Proteins 0.000 description 56
• 239000004365 Protease Substances 0.000 description 53
• 238000013461 design Methods 0.000 description 49
• 230000006334 disulfide bridging Effects 0.000 description 48
• 238000004091 panning Methods 0.000 description 46
• 231100000765 toxin Toxicity 0.000 description 41
• 108700012359 toxins Proteins 0.000 description 40
• 239000003053 toxin Substances 0.000 description 38
• 108020004414 DNA Proteins 0.000 description 37
• 230000002829 reductive effect Effects 0.000 description 36
• 241000588724 Escherichia coli Species 0.000 description 35
• 230000002209 hydrophobic effect Effects 0.000 description 34
• 230000008569 process Effects 0.000 description 33
• 230000005847 immunogenicity Effects 0.000 description 30
• 230000001965 increasing effect Effects 0.000 description 30
• 108091034117 Oligonucleotide Proteins 0.000 description 28
• 125000003275 alpha amino acid group Chemical group 0.000 description 26
• 239000012634 fragment Substances 0.000 description 25
• 239000000047 product Substances 0.000 description 25
• 238000002703 mutagenesis Methods 0.000 description 23
• 239000013598 vector Substances 0.000 description 23
• DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 22
• 239000000243 solution Substances 0.000 description 21
• 231100000350 mutagenesis Toxicity 0.000 description 20
• 230000001603 reducing effect Effects 0.000 description 20
• 108010053481 Antifreeze Proteins Proteins 0.000 description 18
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 18
• 239000003446 ligand Substances 0.000 description 18
• 230000006870 function Effects 0.000 description 17
• 230000035772 mutation Effects 0.000 description 17
• 238000012546 transfer Methods 0.000 description 17
• 229920000642 polymer Polymers 0.000 description 16
• 235000019419 proteases Nutrition 0.000 description 16
• 239000003638 chemical reducing agent Substances 0.000 description 15
• 230000004927 fusion Effects 0.000 description 15
• 239000002245 particle Substances 0.000 description 15
• 108020001580 protein domains Proteins 0.000 description 15
• 230000009467 reduction Effects 0.000 description 15
• 150000003573 thiols Chemical class 0.000 description 15
• 108090000144 Human Proteins Proteins 0.000 description 14
• 102000003839 Human Proteins Human genes 0.000 description 14
• 238000007792 addition Methods 0.000 description 14
• 102000004190 Enzymes Human genes 0.000 description 13
• 108090000790 Enzymes Proteins 0.000 description 13
• 230000009824 affinity maturation Effects 0.000 description 13
• 239000011230 binding agent Substances 0.000 description 13
• FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 13
• 229960003669 carbenicillin Drugs 0.000 description 13
• 229940088598 enzyme Drugs 0.000 description 13
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
• 239000002202 Polyethylene glycol Substances 0.000 description 12
• 230000008901 benefit Effects 0.000 description 12
• 238000010276 construction Methods 0.000 description 12
• RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 12
• 238000000338 in vitro Methods 0.000 description 12
• 108050009312 plexin Proteins 0.000 description 12
• 102000002022 plexin Human genes 0.000 description 12
• 229920001223 polyethylene glycol Polymers 0.000 description 12
• 125000006850 spacer group Chemical group 0.000 description 12
• 239000004471 Glycine Substances 0.000 description 11
• 241001465754 Metazoa Species 0.000 description 11
• 125000001931 aliphatic group Chemical group 0.000 description 11
• 210000000612 antigen-presenting cell Anatomy 0.000 description 11
• 238000003556 assay Methods 0.000 description 11
• 239000011575 calcium Substances 0.000 description 11
• 238000006243 chemical reaction Methods 0.000 description 11
• 229940079593 drug Drugs 0.000 description 11
• 238000002823 phage display Methods 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 239000002340 cardiotoxin Substances 0.000 description 10
• 230000001976 improved effect Effects 0.000 description 10
• 238000002898 library design Methods 0.000 description 10
• 239000003656 tris buffered saline Substances 0.000 description 10
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 10
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 9
• 102000014914 Carrier Proteins Human genes 0.000 description 9
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
• 239000004098 Tetracycline Substances 0.000 description 9
• 102100040247 Tumor necrosis factor Human genes 0.000 description 9
• 102100024598 Tumor necrosis factor ligand superfamily member 10 Human genes 0.000 description 9
• 239000002253 acid Substances 0.000 description 9
• 108091008324 binding proteins Proteins 0.000 description 9
• 229940098773 bovine serum albumin Drugs 0.000 description 9
• 108050003126 conotoxin Proteins 0.000 description 9
• 102000005962 receptors Human genes 0.000 description 9
• 108020003175 receptors Proteins 0.000 description 9
• 230000006798 recombination Effects 0.000 description 9
• 238000005215 recombination Methods 0.000 description 9
• 229960002180 tetracycline Drugs 0.000 description 9
• 229930101283 tetracycline Natural products 0.000 description 9
• 235000019364 tetracycline Nutrition 0.000 description 9
• 150000003522 tetracyclines Chemical class 0.000 description 9
• 210000001519 tissue Anatomy 0.000 description 9
• 229910052720 vanadium Inorganic materials 0.000 description 9
• 101000724917 Calliophis bivirgatus Delta-elapitoxin-Cb1a Proteins 0.000 description 8
• 101000724912 Calliophis bivirgatus Maticotoxin A Proteins 0.000 description 8
• 101000724921 Dendroaspis polylepis polylepis Dendroaspis polylepis MT9 Proteins 0.000 description 8
• 102100037362 Fibronectin Human genes 0.000 description 8
• 108010067306 Fibronectins Proteins 0.000 description 8
• 101000783591 Micrurus clarki Clarkitoxin-1 Proteins 0.000 description 8
• 101000963932 Micrurus frontalis Frontoxin II Proteins 0.000 description 8
• 101000783588 Micrurus mipartitus Mipartoxin-1 Proteins 0.000 description 8
• 101000963935 Micrurus nigrocinctus Nicotinic acetylcholine receptor-binding protein Mnn-1A Proteins 0.000 description 8
• 101000964147 Micrurus nigrocinctus Nicotinic acetylcholine receptor-binding protein Mnn-3C Proteins 0.000 description 8
• 101000964140 Micrurus nigrocinctus Nicotinic acetylcholine receptor-binding protein Mnn-4 Proteins 0.000 description 8
• 101000724922 Micrurus pyrrhocryptus Venom protein E2 Proteins 0.000 description 8
• 101000724923 Micrurus surinamensis Short neurotoxin MS11 Proteins 0.000 description 8
• 101000724924 Naja kaouthia Nakoroxin Proteins 0.000 description 8
• 101000783356 Naja sputatrix Cytotoxin Proteins 0.000 description 8
• 101000963934 Ophiophagus hannah Neurotoxin Oh9-1 Proteins 0.000 description 8
• 101000724920 Ophiophagus hannah Short neurotoxin OH-26 Proteins 0.000 description 8
• 101000963927 Ophiophagus hannah Short neurotoxin OH-32 Proteins 0.000 description 8
• 101000724910 Ophiophagus hannah Short neurotoxin OH-46 Proteins 0.000 description 8
• 101000964138 Ophiophagus hannah Short neurotoxin OH-5 Proteins 0.000 description 8
• 101000724915 Ophiophagus hannah Short neurotoxin SNTX11 Proteins 0.000 description 8
• 101000724916 Ophiophagus hannah Short neurotoxin SNTX14 Proteins 0.000 description 8
• 101000724918 Ophiophagus hannah Short neurotoxin SNTX26 Proteins 0.000 description 8
• 101000724908 Ophiophagus hannah Short neurotoxin SNTX6 Proteins 0.000 description 8
• 101000964146 Ophiophagus hannah Weak neurotoxin WNTX33 Proteins 0.000 description 8
• 101000964133 Oxyuranus microlepidotus Toxin 3FTx-Oxy5 Proteins 0.000 description 8
• 101000724919 Oxyuranus scutellatus scutellatus Scutelatoxin Proteins 0.000 description 8
• 101000964145 Oxyuranus scutellatus scutellatus Short neurotoxin 3 Proteins 0.000 description 8
• 108700012411 TNFSF10 Proteins 0.000 description 8
• 108020005038 Terminator Codon Proteins 0.000 description 8
• 150000007513 acids Chemical class 0.000 description 8
• 231100000677 cardiotoxin Toxicity 0.000 description 8
• 210000000805 cytoplasm Anatomy 0.000 description 8
• 239000000499 gel Substances 0.000 description 8
• 230000000968 intestinal effect Effects 0.000 description 8
• 239000007800 oxidant agent Substances 0.000 description 8
• 230000003647 oxidation Effects 0.000 description 8
• 238000007254 oxidation reaction Methods 0.000 description 8
• 239000013612 plasmid Substances 0.000 description 8
• 230000002685 pulmonary effect Effects 0.000 description 8
• 238000000746 purification Methods 0.000 description 8
• 238000012163 sequencing technique Methods 0.000 description 8
• 108700028369 Alleles Proteins 0.000 description 7
• 239000004475 Arginine Substances 0.000 description 7
• 235000004035 Cryptotaenia japonica Nutrition 0.000 description 7
• 102000004127 Cytokines Human genes 0.000 description 7
• 108090000695 Cytokines Proteins 0.000 description 7
• 241000196324 Embryophyta Species 0.000 description 7
• 108060003393 Granulin Proteins 0.000 description 7
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 7
• 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 7
• 241000239226 Scorpiones Species 0.000 description 7
• 241000270295 Serpentes Species 0.000 description 7
• 102000013275 Somatomedins Human genes 0.000 description 7
• 210000001744 T-lymphocyte Anatomy 0.000 description 7
• 102100036034 Thrombospondin-1 Human genes 0.000 description 7
• 102000007641 Trefoil Factors Human genes 0.000 description 7
• 235000015724 Trifolium pratense Nutrition 0.000 description 7
• 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 7
• 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 7
• 230000002528 anti-freeze Effects 0.000 description 7
• 239000000872 buffer Substances 0.000 description 7
• 210000004899 c-terminal region Anatomy 0.000 description 7
• 230000000295 complement effect Effects 0.000 description 7
• 239000003431 cross linking reagent Substances 0.000 description 7
• 238000009472 formulation Methods 0.000 description 7
• 102000017941 granulin Human genes 0.000 description 7
• 150000002500 ions Chemical class 0.000 description 7
• 230000007246 mechanism Effects 0.000 description 7
• 239000012528 membrane Substances 0.000 description 7
• 230000037361 pathway Effects 0.000 description 7
• 239000008188 pellet Substances 0.000 description 7
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 239000006228 supernatant Substances 0.000 description 7
• 230000032258 transport Effects 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 229910052725 zinc Inorganic materials 0.000 description 7
• 239000011701 zinc Substances 0.000 description 7
• 102000000844 Cell Surface Receptors Human genes 0.000 description 6
• 108010001857 Cell Surface Receptors Proteins 0.000 description 6
• 108060002063 Cyclotide Proteins 0.000 description 6
• 108700021041 Disintegrin Proteins 0.000 description 6
• 238000002965 ELISA Methods 0.000 description 6
• 108010024636 Glutathione Proteins 0.000 description 6
• 108060003951 Immunoglobulin Proteins 0.000 description 6
• 239000006142 Luria-Bertani Agar Substances 0.000 description 6
• 108010070047 Notch Receptors Proteins 0.000 description 6
• 108091028043 Nucleic acid sequence Proteins 0.000 description 6
• 108010007389 Trefoil Factors Proteins 0.000 description 6
• ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 6
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
• 230000004075 alteration Effects 0.000 description 6
• 125000000539 amino acid group Chemical group 0.000 description 6
• 238000004458 analytical method Methods 0.000 description 6
• ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
• 238000004422 calculation algorithm Methods 0.000 description 6
• 230000015556 catabolic process Effects 0.000 description 6
• 239000001913 cellulose Substances 0.000 description 6
• 229920002678 cellulose Polymers 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• 239000003153 chemical reaction reagent Substances 0.000 description 6
• 238000006731 degradation reaction Methods 0.000 description 6
• 238000009826 distribution Methods 0.000 description 6
• 229910052739 hydrogen Inorganic materials 0.000 description 6
• 230000002163 immunogen Effects 0.000 description 6
• 102000018358 immunoglobulin Human genes 0.000 description 6
• 239000003112 inhibitor Substances 0.000 description 6
• 235000018977 lysine Nutrition 0.000 description 6
• 238000004519 manufacturing process Methods 0.000 description 6
• 230000035800 maturation Effects 0.000 description 6
• 108091008146 restriction endonucleases Proteins 0.000 description 6
• 230000028327 secretion Effects 0.000 description 6
• 239000003998 snake venom Substances 0.000 description 6
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
• 238000003786 synthesis reaction Methods 0.000 description 6
• 238000012360 testing method Methods 0.000 description 6
• 230000001225 therapeutic effect Effects 0.000 description 6
• VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 6
• 231100000611 venom Toxicity 0.000 description 6
• 229910052727 yttrium Inorganic materials 0.000 description 6
• BVGLZNQZEYAYBJ-QWZQWHGGSA-N α-cobratoxin Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)CC1=CC=C(O)C=C1 BVGLZNQZEYAYBJ-QWZQWHGGSA-N 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 102100032937 CD40 ligand Human genes 0.000 description 5
• 108010006303 Carboxypeptidases Proteins 0.000 description 5
• 102000005367 Carboxypeptidases Human genes 0.000 description 5
• 102000005600 Cathepsins Human genes 0.000 description 5
• 108010084457 Cathepsins Proteins 0.000 description 5
• 102000053602 DNA Human genes 0.000 description 5
• 101710178505 Defensin-1 Proteins 0.000 description 5
• 102000005593 Endopeptidases Human genes 0.000 description 5
• 108010059378 Endopeptidases Proteins 0.000 description 5
• 101800003838 Epidermal growth factor Proteins 0.000 description 5
• 241001524679 Escherichia virus M13 Species 0.000 description 5
• 108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
• 102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
• 241000238631 Hexapoda Species 0.000 description 5
• 101100369992 Homo sapiens TNFSF10 gene Proteins 0.000 description 5
• 241000269907 Pleuronectes platessa Species 0.000 description 5
• 239000004743 Polypropylene Substances 0.000 description 5
• 102100033237 Pro-epidermal growth factor Human genes 0.000 description 5
• 108010076504 Protein Sorting Signals Proteins 0.000 description 5
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
• 101710182223 Toxin B Proteins 0.000 description 5
• 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 description 5
• 239000000427 antigen Substances 0.000 description 5
• 108091007433 antigens Proteins 0.000 description 5
• 102000036639 antigens Human genes 0.000 description 5
• 230000001580 bacterial effect Effects 0.000 description 5
• 238000006664 bond formation reaction Methods 0.000 description 5
• 229910052791 calcium Inorganic materials 0.000 description 5
• 150000001720 carbohydrates Chemical class 0.000 description 5
• 235000014633 carbohydrates Nutrition 0.000 description 5
• 238000012412 chemical coupling Methods 0.000 description 5
• 238000012377 drug delivery Methods 0.000 description 5
• 229940066758 endopeptidases Drugs 0.000 description 5
• 229940116977 epidermal growth factor Drugs 0.000 description 5
• 229960003180 glutathione Drugs 0.000 description 5
• 239000005090 green fluorescent protein Substances 0.000 description 5
• 125000001165 hydrophobic group Chemical group 0.000 description 5
• 238000001727 in vivo Methods 0.000 description 5
• 102000006495 integrins Human genes 0.000 description 5
• 108010044426 integrins Proteins 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 108020004999 messenger RNA Proteins 0.000 description 5
• 230000001590 oxidative effect Effects 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 229920001155 polypropylene Polymers 0.000 description 5
• 238000002360 preparation method Methods 0.000 description 5
• 238000011084 recovery Methods 0.000 description 5
• 229910052717 sulfur Inorganic materials 0.000 description 5
• 230000009466 transformation Effects 0.000 description 5
• 238000005406 washing Methods 0.000 description 5
• 108010049777 Ankyrins Proteins 0.000 description 4
• 102000008102 Ankyrins Human genes 0.000 description 4
• 241000239290 Araneae Species 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 4
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
• 101710167800 Capsid assembly scaffolding protein Proteins 0.000 description 4
• 108010086232 Cobra Neurotoxin Proteins Proteins 0.000 description 4
• 108091035707 Consensus sequence Proteins 0.000 description 4
• 102000001189 Cyclic Peptides Human genes 0.000 description 4
• 108010069514 Cyclic Peptides Proteins 0.000 description 4
• 102000018389 Exopeptidases Human genes 0.000 description 4
• 108010091443 Exopeptidases Proteins 0.000 description 4
• 241000237858 Gastropoda Species 0.000 description 4
• HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 4
• 101000924577 Homo sapiens Adenomatous polyposis coli protein Proteins 0.000 description 4
• KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 4
• 239000004472 Lysine Substances 0.000 description 4
• PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical group CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 4
• 206010028980 Neoplasm Diseases 0.000 description 4
• 101710130420 Probable capsid assembly scaffolding protein Proteins 0.000 description 4
• 101710204410 Scaffold protein Proteins 0.000 description 4
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 4
• PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
• 108010046722 Thrombospondin 1 Proteins 0.000 description 4
• 230000009471 action Effects 0.000 description 4
• 231100000659 animal toxin Toxicity 0.000 description 4
• 238000000137 annealing Methods 0.000 description 4
• 239000011324 bead Substances 0.000 description 4
• 210000004369 blood Anatomy 0.000 description 4
• 239000008280 blood Substances 0.000 description 4
• 230000008499 blood brain barrier function Effects 0.000 description 4
• 210000001218 blood-brain barrier Anatomy 0.000 description 4
• 229910052799 carbon Inorganic materials 0.000 description 4
• 230000003197 catalytic effect Effects 0.000 description 4
• 230000001413 cellular effect Effects 0.000 description 4
• 238000012512 characterization method Methods 0.000 description 4
• 230000007423 decrease Effects 0.000 description 4
• 210000004443 dendritic cell Anatomy 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 238000012938 design process Methods 0.000 description 4
• 230000029087 digestion Effects 0.000 description 4
• 238000010790 dilution Methods 0.000 description 4
• 239000012895 dilution Substances 0.000 description 4
• 125000002228 disulfide group Chemical group 0.000 description 4
• 238000009510 drug design Methods 0.000 description 4
• 239000000839 emulsion Substances 0.000 description 4
• 108020001507 fusion proteins Proteins 0.000 description 4
• 102000037865 fusion proteins Human genes 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 239000007788 liquid Substances 0.000 description 4
• 229910052751 metal Inorganic materials 0.000 description 4
• 239000002184 metal Substances 0.000 description 4
• 230000004048 modification Effects 0.000 description 4
• 238000012986 modification Methods 0.000 description 4
• 231100000219 mutagenic Toxicity 0.000 description 4
• 230000003505 mutagenic effect Effects 0.000 description 4
• YIEDSISPYKQADU-UHFFFAOYSA-N n-acetyl-n-[2-methyl-4-[(2-methylphenyl)diazenyl]phenyl]acetamide Chemical compound C1=C(C)C(N(C(C)=O)C(=O)C)=CC=C1N=NC1=CC=CC=C1C YIEDSISPYKQADU-UHFFFAOYSA-N 0.000 description 4
• 239000002953 phosphate buffered saline Substances 0.000 description 4
• 235000019833 protease Nutrition 0.000 description 4
• 239000003001 serine protease inhibitor Substances 0.000 description 4
• 150000003384 small molecules Chemical class 0.000 description 4
• 239000002904 solvent Substances 0.000 description 4
• 230000009870 specific binding Effects 0.000 description 4
• 239000002708 spider venom Substances 0.000 description 4
• 230000014616 translation Effects 0.000 description 4
• 229910052721 tungsten Inorganic materials 0.000 description 4
• 239000002435 venom Substances 0.000 description 4
• 210000001048 venom Anatomy 0.000 description 4
• 108091058551 α-conotoxin Proteins 0.000 description 4
• MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
• 102100034540 Adenomatous polyposis coli protein Human genes 0.000 description 3
• 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
• 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
• 108091005502 Aspartic proteases Proteins 0.000 description 3
• 102000035101 Aspartic proteases Human genes 0.000 description 3
• 102100027207 CD27 antigen Human genes 0.000 description 3
• 108010029697 CD40 Ligand Proteins 0.000 description 3
• 102000005701 Calcium-Binding Proteins Human genes 0.000 description 3
• 108010045403 Calcium-Binding Proteins Proteins 0.000 description 3
• 108010078791 Carrier Proteins Proteins 0.000 description 3
• 108090000267 Cathepsin C Proteins 0.000 description 3
• 102000003902 Cathepsin C Human genes 0.000 description 3
• 229920002101 Chitin Polymers 0.000 description 3
• 239000004971 Cross linker Substances 0.000 description 3
• 102000005927 Cysteine Proteases Human genes 0.000 description 3
• 108010005843 Cysteine Proteases Proteins 0.000 description 3
• 101710178510 Defensin-2 Proteins 0.000 description 3
• 108010002069 Defensins Proteins 0.000 description 3
• 102000000541 Defensins Human genes 0.000 description 3
• 101001130157 Dioclea sclerocarpa Lectin alpha chain Proteins 0.000 description 3
• 108090000204 Dipeptidase 1 Proteins 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 102000016970 Follistatin Human genes 0.000 description 3
• 108010014612 Follistatin Proteins 0.000 description 3
• 108010053070 Glutathione Disulfide Proteins 0.000 description 3
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 3
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 3
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 3
• 101000795167 Homo sapiens Tumor necrosis factor receptor superfamily member 13B Proteins 0.000 description 3
• 101000801228 Homo sapiens Tumor necrosis factor receptor superfamily member 1A Proteins 0.000 description 3
• 101000679903 Homo sapiens Tumor necrosis factor receptor superfamily member 25 Proteins 0.000 description 3
• 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 description 3
• 108091006905 Human Serum Albumin Proteins 0.000 description 3
• 102000008100 Human Serum Albumin Human genes 0.000 description 3
• 102100022339 Integrin alpha-L Human genes 0.000 description 3
• 108010065805 Interleukin-12 Proteins 0.000 description 3
• 102000013462 Interleukin-12 Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 102000004388 Interleukin-4 Human genes 0.000 description 3
• 108090000978 Interleukin-4 Proteins 0.000 description 3
• 108090001005 Interleukin-6 Proteins 0.000 description 3
• 102000004889 Interleukin-6 Human genes 0.000 description 3
• QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
• WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
• ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
• QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
• ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 3
• 102000019298 Lipocalin Human genes 0.000 description 3
• 108050006654 Lipocalin Proteins 0.000 description 3
• 108010064548 Lymphocyte Function-Associated Antigen-1 Proteins 0.000 description 3
• 102000004083 Lymphotoxin-alpha Human genes 0.000 description 3
• 108090000542 Lymphotoxin-alpha Proteins 0.000 description 3
• 101000800755 Naja oxiana Alpha-elapitoxin-Nno2a Proteins 0.000 description 3
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 3
• 229940122055 Serine protease inhibitor Drugs 0.000 description 3
• 101710102218 Serine protease inhibitor Proteins 0.000 description 3
• 230000006044 T cell activation Effects 0.000 description 3
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 3
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 3
• 108010034949 Thyroglobulin Proteins 0.000 description 3
• 102000009843 Thyroglobulin Human genes 0.000 description 3
• 108090000631 Trypsin Proteins 0.000 description 3
• 102000004142 Trypsin Human genes 0.000 description 3
• 229940122618 Trypsin inhibitor Drugs 0.000 description 3
• 101710162629 Trypsin inhibitor Proteins 0.000 description 3
• QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
• 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 description 3
• 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 3
• 102100029675 Tumor necrosis factor receptor superfamily member 13B Human genes 0.000 description 3
• 102100033732 Tumor necrosis factor receptor superfamily member 1A Human genes 0.000 description 3
• 102100022203 Tumor necrosis factor receptor superfamily member 25 Human genes 0.000 description 3
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 3
• 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 230000002776 aggregation Effects 0.000 description 3
• 238000004220 aggregation Methods 0.000 description 3
• 235000004279 alanine Nutrition 0.000 description 3
• 239000002776 alpha toxin Substances 0.000 description 3
• 230000030741 antigen processing and presentation Effects 0.000 description 3
• 125000003118 aryl group Chemical group 0.000 description 3
• 102000006635 beta-lactamase Human genes 0.000 description 3
• 239000012620 biological material Substances 0.000 description 3
• 210000000170 cell membrane Anatomy 0.000 description 3
• 239000003795 chemical substances by application Substances 0.000 description 3
• 239000011248 coating agent Substances 0.000 description 3
• 238000000576 coating method Methods 0.000 description 3
• 229910052802 copper Inorganic materials 0.000 description 3
• 239000010949 copper Substances 0.000 description 3
• 238000004132 cross linking Methods 0.000 description 3
• 239000013078 crystal Substances 0.000 description 3
• 125000004122 cyclic group Chemical group 0.000 description 3
• 230000001351 cycling effect Effects 0.000 description 3
• 230000001086 cytosolic effect Effects 0.000 description 3
• 238000012217 deletion Methods 0.000 description 3
• 230000037430 deletion Effects 0.000 description 3
• 238000001212 derivatisation Methods 0.000 description 3
• 239000000539 dimer Substances 0.000 description 3
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 3
• VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 3
• 238000004520 electroporation Methods 0.000 description 3
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 3
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 3
• 229910052731 fluorine Inorganic materials 0.000 description 3
• 229930195712 glutamate Natural products 0.000 description 3
• YPZRWBKMTBYPTK-BJDJZHNGSA-N glutathione disulfide Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@H](C(=O)NCC(O)=O)CSSC[C@@H](C(=O)NCC(O)=O)NC(=O)CC[C@H](N)C(O)=O YPZRWBKMTBYPTK-BJDJZHNGSA-N 0.000 description 3
• 238000002744 homologous recombination Methods 0.000 description 3
• 230000006801 homologous recombination Effects 0.000 description 3
• 230000006872 improvement Effects 0.000 description 3
• 239000000543 intermediate Substances 0.000 description 3
• 229910052740 iodine Inorganic materials 0.000 description 3
• 230000002427 irreversible effect Effects 0.000 description 3
• 238000006317 isomerization reaction Methods 0.000 description 3
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
• 229930027917 kanamycin Natural products 0.000 description 3
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
• 229960000318 kanamycin Drugs 0.000 description 3
• 229930182823 kanamycin A Natural products 0.000 description 3
• 150000002632 lipids Chemical class 0.000 description 3
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
• 239000000463 material Substances 0.000 description 3
• 230000000813 microbial effect Effects 0.000 description 3
• 239000003471 mutagenic agent Substances 0.000 description 3
• 229910052757 nitrogen Inorganic materials 0.000 description 3
• 239000002773 nucleotide Substances 0.000 description 3
• 125000003729 nucleotide group Chemical group 0.000 description 3
• 230000008520 organization Effects 0.000 description 3
• 108010039893 pacifastin Proteins 0.000 description 3
• 230000035515 penetration Effects 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 239000013615 primer Substances 0.000 description 3
• 230000004845 protein aggregation Effects 0.000 description 3
• 238000002818 protein evolution Methods 0.000 description 3
• 230000012846 protein folding Effects 0.000 description 3
• 230000007115 recruitment Effects 0.000 description 3
• 230000000717 retained effect Effects 0.000 description 3
• 230000035945 sensitivity Effects 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 238000003860 storage Methods 0.000 description 3
• 108020001568 subdomains Proteins 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 239000008399 tap water Substances 0.000 description 3
• 235000020679 tap water Nutrition 0.000 description 3
• 230000008685 targeting Effects 0.000 description 3
• 229960002175 thyroglobulin Drugs 0.000 description 3
• 239000012588 trypsin Substances 0.000 description 3
• 239000002753 trypsin inhibitor Substances 0.000 description 3
• 229940035893 uracil Drugs 0.000 description 3
• 230000004572 zinc-binding Effects 0.000 description 3
• 108091058549 μ-conotoxin Proteins 0.000 description 3
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
• LEBVLXFERQHONN-UHFFFAOYSA-N 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide Chemical compound CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-UHFFFAOYSA-N 0.000 description 2
• NGNQZCDZXSOVQU-UHFFFAOYSA-N 8,16,18,26,34,36-hexahydroxyhentetracontane-2,6,10,14,24,28,32-heptone Chemical compound CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCCCC(O)CC(O)CC(=O)CCCC(=O)CC(O)CC(=O)CCCC(C)=O NGNQZCDZXSOVQU-UHFFFAOYSA-N 0.000 description 2
• 241000242759 Actiniaria Species 0.000 description 2
• 108010072151 Agouti Signaling Protein Proteins 0.000 description 2
• 102000006822 Agouti Signaling Protein Human genes 0.000 description 2
• 102000004400 Aminopeptidases Human genes 0.000 description 2
• 108090000915 Aminopeptidases Proteins 0.000 description 2
• 101000654311 Androctonus australis Alpha-mammal toxin AaH2 Proteins 0.000 description 2
• 244000118350 Andrographis paniculata Species 0.000 description 2
• 101001023095 Anemonia sulcata Delta-actitoxin-Avd1a Proteins 0.000 description 2
• 101000641989 Araneus ventricosus Kunitz-type U1-aranetoxin-Av1a Proteins 0.000 description 2
• 102100038080 B-cell receptor CD22 Human genes 0.000 description 2
• 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 description 2
• 108091007065 BIRCs Proteins 0.000 description 2
• 231100000699 Bacterial toxin Toxicity 0.000 description 2
• 102000004506 Blood Proteins Human genes 0.000 description 2
• 108010017384 Blood Proteins Proteins 0.000 description 2
• 102000001893 Bone Morphogenetic Protein Receptors Human genes 0.000 description 2
• 108010040422 Bone Morphogenetic Protein Receptors Proteins 0.000 description 2
• 101710109559 Bucain Proteins 0.000 description 2
• 101710152682 Bucandin Proteins 0.000 description 2
• 101000685088 Buthus occitanus tunetanus Alpha-toxin Bot1 Proteins 0.000 description 2
• 101000654313 Buthus occitanus tunetanus Neurotoxin Bot2 Proteins 0.000 description 2
• 101150013553 CD40 gene Proteins 0.000 description 2
• 102100022002 CD59 glycoprotein Human genes 0.000 description 2
• 108010080937 Carboxypeptidases A Proteins 0.000 description 2
• 102000000496 Carboxypeptidases A Human genes 0.000 description 2
• 101001028691 Carybdea rastonii Toxin CrTX-A Proteins 0.000 description 2
• 108010059081 Cathepsin A Proteins 0.000 description 2
• 102000005572 Cathepsin A Human genes 0.000 description 2
• 102000003908 Cathepsin D Human genes 0.000 description 2
• 108090000258 Cathepsin D Proteins 0.000 description 2
• 102000004178 Cathepsin E Human genes 0.000 description 2
• 108090000611 Cathepsin E Proteins 0.000 description 2
• 101000685083 Centruroides infamatus Beta-toxin Cii1 Proteins 0.000 description 2
• 101000685085 Centruroides noxius Toxin Cn1 Proteins 0.000 description 2
• 101000716536 Centruroides sculpturatus Beta-toxin CsEI Proteins 0.000 description 2
• 108010012236 Chemokines Proteins 0.000 description 2
• 102000019034 Chemokines Human genes 0.000 description 2
• 101001028688 Chironex fleckeri Toxin CfTX-1 Proteins 0.000 description 2
• 108010016640 Cobra Cardiotoxin Proteins Proteins 0.000 description 2
• 102100035932 Cocaine- and amphetamine-regulated transcript protein Human genes 0.000 description 2
• 108010028774 Complement C1 Proteins 0.000 description 2
• 102100030149 Complement C1r subcomponent Human genes 0.000 description 2
• 102100025406 Complement C1s subcomponent Human genes 0.000 description 2
• RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
• 241000484025 Cuniculus Species 0.000 description 2
• 241000252233 Cyprinus carpio Species 0.000 description 2
• 101000644407 Cyriopagopus schmidti U6-theraphotoxin-Hs1a Proteins 0.000 description 2
• 230000004568 DNA-binding Effects 0.000 description 2
• 101100208241 Danio rerio thbs3a gene Proteins 0.000 description 2
• 108010016626 Dipeptides Proteins 0.000 description 2
• 101800001224 Disintegrin Proteins 0.000 description 2
• 102000012545 EGF-like domains Human genes 0.000 description 2
• 108050002150 EGF-like domains Proteins 0.000 description 2
• 101000609473 Ecballium elaterium Trypsin inhibitor 2 Proteins 0.000 description 2
• 102100023795 Elafin Human genes 0.000 description 2
• 101150064015 FAS gene Proteins 0.000 description 2
• 102100028071 Fibroblast growth factor 7 Human genes 0.000 description 2
• 108090000385 Fibroblast growth factor 7 Proteins 0.000 description 2
• 241000233866 Fungi Species 0.000 description 2
• 102000005720 Glutathione transferase Human genes 0.000 description 2
• 108010070675 Glutathione transferase Proteins 0.000 description 2
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 2
• 108010042283 HSP40 Heat-Shock Proteins Proteins 0.000 description 2
• 101710121697 Heat-stable enterotoxin Proteins 0.000 description 2
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
• 101000588935 Heteractis crispa Delta-stichotoxin-Hcr1b Proteins 0.000 description 2
• 101000588929 Heteractis crispa Delta-stichotoxin-Hcr1e Proteins 0.000 description 2
• 101000588275 Heteractis magnifica Delta-stichotoxin-Rpa1b Proteins 0.000 description 2
• 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 description 2
• 101000868215 Homo sapiens CD40 ligand Proteins 0.000 description 2
• 101000897400 Homo sapiens CD59 glycoprotein Proteins 0.000 description 2
• 101000715592 Homo sapiens Cocaine- and amphetamine-regulated transcript protein Proteins 0.000 description 2
• 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 description 2
• 101000659879 Homo sapiens Thrombospondin-1 Proteins 0.000 description 2
• 101000633605 Homo sapiens Thrombospondin-2 Proteins 0.000 description 2
• 101000830600 Homo sapiens Tumor necrosis factor ligand superfamily member 13 Proteins 0.000 description 2
• 101000597779 Homo sapiens Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 2
• 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 2
• 101000801227 Homo sapiens Tumor necrosis factor receptor superfamily member 19 Proteins 0.000 description 2
• 101000679921 Homo sapiens Tumor necrosis factor receptor superfamily member 21 Proteins 0.000 description 2
• 101000611023 Homo sapiens Tumor necrosis factor receptor superfamily member 6 Proteins 0.000 description 2
• 101000597785 Homo sapiens Tumor necrosis factor receptor superfamily member 6B Proteins 0.000 description 2
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 2
• 101000654277 Hottentotta tamulus Neurotoxin-2 Proteins 0.000 description 2
• MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
• 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
• 102000055031 Inhibitor of Apoptosis Proteins Human genes 0.000 description 2
• 108010065637 Interleukin-23 Proteins 0.000 description 2
• 102000013264 Interleukin-23 Human genes 0.000 description 2
• 102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 2
• 101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 2
• XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
• 102100020880 Kit ligand Human genes 0.000 description 2
• ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
• AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
• KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
• FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
• COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
• KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
• 102000007330 LDL Lipoproteins Human genes 0.000 description 2
• 108010007622 LDL Lipoproteins Proteins 0.000 description 2
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 2
• 101710106949 Long neurotoxin 1 Proteins 0.000 description 2
• 102000003959 Lymphotoxin-beta Human genes 0.000 description 2
• 108090000362 Lymphotoxin-beta Proteins 0.000 description 2
• 101710175625 Maltose/maltodextrin-binding periplasmic protein Proteins 0.000 description 2
• 102000018697 Membrane Proteins Human genes 0.000 description 2
• 108010052285 Membrane Proteins Proteins 0.000 description 2
• 102000005741 Metalloproteases Human genes 0.000 description 2
• 108010006035 Metalloproteases Proteins 0.000 description 2
• 241000699666 Mus <mouse, genus> Species 0.000 description 2
• 101000597780 Mus musculus Tumor necrosis factor ligand superfamily member 18 Proteins 0.000 description 2
• 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 description 2
• 101000783409 Naja anchietae Long neurotoxin 1 Proteins 0.000 description 2
• 101000744155 Naja atra Cytotoxin 3 Proteins 0.000 description 2
• 101000800759 Naja mossambica Short neurotoxin 1 Proteins 0.000 description 2
• 101000800760 Naja oxiana Short neurotoxin 1 Proteins 0.000 description 2
• 108010025020 Nerve Growth Factor Proteins 0.000 description 2
• 101710138657 Neurotoxin Proteins 0.000 description 2
• 108020004485 Nonsense Codon Proteins 0.000 description 2
• 108700026244 Open Reading Frames Proteins 0.000 description 2
• 108010077077 Osteonectin Proteins 0.000 description 2
• 102000009890 Osteonectin Human genes 0.000 description 2
• 101000679608 Phaeosphaeria nodorum (strain SN15 / ATCC MYA-4574 / FGSC 10173) Cysteine rich necrotrophic effector Tox1 Proteins 0.000 description 2
• 108010001014 Plasminogen Activators Proteins 0.000 description 2
• 102000001938 Plasminogen Activators Human genes 0.000 description 2
• 229920002594 Polyethylene Glycol 8000 Polymers 0.000 description 2
• 108091000054 Prion Proteins 0.000 description 2
• 102000029797 Prion Human genes 0.000 description 2
• ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
• 108091081062 Repeated sequence (DNA) Proteins 0.000 description 2
• 101001049892 Scorpio palmatus Potassium channel toxin alpha-KTx 6.2 Proteins 0.000 description 2
• 102000012479 Serine Proteases Human genes 0.000 description 2
• 108010022999 Serine Proteases Proteins 0.000 description 2
• 244000061456 Solanum tuberosum Species 0.000 description 2
• 235000002595 Solanum tuberosum Nutrition 0.000 description 2
• 101000588932 Stichodactyla helianthus Delta-stichotoxin-She1a Proteins 0.000 description 2
• 108010090804 Streptavidin Proteins 0.000 description 2
• PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 2
• 241000254109 Tenebrio molitor Species 0.000 description 2
• 101150116166 Thbs3 gene Proteins 0.000 description 2
• 102100029529 Thrombospondin-2 Human genes 0.000 description 2
• 102100029524 Thrombospondin-3 Human genes 0.000 description 2
• CMCSZZOVEJFBEY-UHFFFAOYSA-N Toxin FS2 Chemical compound C1CC(C)(O)C=CC1(C)C1(C)CC(O)C=C1CO CMCSZZOVEJFBEY-UHFFFAOYSA-N 0.000 description 2
• 102000004060 Transforming Growth Factor-beta Type II Receptor Human genes 0.000 description 2
• 108010082684 Transforming Growth Factor-beta Type II Receptor Proteins 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 108060008683 Tumor Necrosis Factor Receptor Proteins 0.000 description 2
• 102100024585 Tumor necrosis factor ligand superfamily member 13 Human genes 0.000 description 2
• 102100024587 Tumor necrosis factor ligand superfamily member 15 Human genes 0.000 description 2
• 102100035283 Tumor necrosis factor ligand superfamily member 18 Human genes 0.000 description 2
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 description 2
• 102100032100 Tumor necrosis factor ligand superfamily member 8 Human genes 0.000 description 2
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 2
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 2
• 102100032236 Tumor necrosis factor receptor superfamily member 11B Human genes 0.000 description 2
• 102100029690 Tumor necrosis factor receptor superfamily member 13C Human genes 0.000 description 2
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 description 2
• 102100033726 Tumor necrosis factor receptor superfamily member 17 Human genes 0.000 description 2
• 102100033760 Tumor necrosis factor receptor superfamily member 19 Human genes 0.000 description 2
• 102100022205 Tumor necrosis factor receptor superfamily member 21 Human genes 0.000 description 2
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 2
• 102100035284 Tumor necrosis factor receptor superfamily member 6B Human genes 0.000 description 2
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 2
• 102000000523 Type II Activin Receptors Human genes 0.000 description 2
• 108010041546 Type II Activin Receptors Proteins 0.000 description 2
• 102400000757 Ubiquitin Human genes 0.000 description 2
• 108090000848 Ubiquitin Proteins 0.000 description 2
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
• KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
• 102100035140 Vitronectin Human genes 0.000 description 2
• 238000009825 accumulation Methods 0.000 description 2
• 230000006978 adaptation Effects 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 238000001042 affinity chromatography Methods 0.000 description 2
• 238000000246 agarose gel electrophoresis Methods 0.000 description 2
• 239000000556 agonist Substances 0.000 description 2
• 108010055359 alpha-cobratoxin Proteins 0.000 description 2
• 230000003321 amplification Effects 0.000 description 2
• 239000005557 antagonist Substances 0.000 description 2
• 229940009098 aspartate Drugs 0.000 description 2
• OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 2
• 239000000688 bacterial toxin Substances 0.000 description 2
• 230000004888 barrier function Effects 0.000 description 2
• 230000009286 beneficial effect Effects 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 239000012472 biological sample Substances 0.000 description 2
• 229960000074 biopharmaceutical Drugs 0.000 description 2
• 229960003150 bupivacaine Drugs 0.000 description 2
• 244000309466 calf Species 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 108010011091 cardiotoxin V Proteins 0.000 description 2
• GCDJGEWSHKXMFB-KLSUCABJSA-N cardiotoxin, cobra Chemical compound C([C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H]2CSSC[C@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]3CCCN3C(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=3C=CC=CC=3)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]3N(CCC3)C2=O)CSSC[C@@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N1)C(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]1C(N2CCC[C@H]2C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]1C(N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(O)=O)[C@@H](C)O)=O)C(C)C)C(C)C)=O)[C@@H](C)O)C1=CC=C(O)C=C1 GCDJGEWSHKXMFB-KLSUCABJSA-N 0.000 description 2
• 239000000969 carrier Substances 0.000 description 2
• 238000006555 catalytic reaction Methods 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 239000006285 cell suspension Substances 0.000 description 2
• 238000010367 cloning Methods 0.000 description 2
• 108010047295 complement receptors Proteins 0.000 description 2
• 102000006834 complement receptors Human genes 0.000 description 2
• 150000001875 compounds Chemical class 0.000 description 2
• 230000021615 conjugation Effects 0.000 description 2
• 238000011109 contamination Methods 0.000 description 2
• 230000008878 coupling Effects 0.000 description 2
• 239000007822 coupling agent Substances 0.000 description 2
• 238000010168 coupling process Methods 0.000 description 2
• 238000005859 coupling reaction Methods 0.000 description 2
• 230000001186 cumulative effect Effects 0.000 description 2
• 210000000172 cytosol Anatomy 0.000 description 2
• 238000002296 dynamic light scattering Methods 0.000 description 2
• 238000010828 elution Methods 0.000 description 2
• 239000003623 enhancer Substances 0.000 description 2
• 108010033998 erabutoxin A Proteins 0.000 description 2
• SRWAKURFIXSMSY-YIPRCOCFSA-N erabutoxin a Chemical compound C([C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CSSC[C@H]2C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=3C4=CC=CC=C4NC=3)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N1)=O)CSSC[C@@H](C(N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N2)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H]1C(N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]1C(N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)C(C)C)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C1=CC=CC=C1 SRWAKURFIXSMSY-YIPRCOCFSA-N 0.000 description 2
• WITZDNDAZYTMTC-MJQGTENLSA-N erabutoxin b Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]([C@@H](C)CC)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]1N(C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=2C3=CC=CC=C3NC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=2NC=NC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H]2N(CCC2)C(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC=2NC=NC=2)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)CCC1 WITZDNDAZYTMTC-MJQGTENLSA-N 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 230000002349 favourable effect Effects 0.000 description 2
• 108010010962 ferredoxin-thioredoxin reductase Proteins 0.000 description 2
• 230000002538 fungal effect Effects 0.000 description 2
• 210000001035 gastrointestinal tract Anatomy 0.000 description 2
• 238000012248 genetic selection Methods 0.000 description 2
• 230000013595 glycosylation Effects 0.000 description 2
• 238000006206 glycosylation reaction Methods 0.000 description 2
• 239000008187 granular material Substances 0.000 description 2
• 239000003102 growth factor Substances 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 229960002897 heparin Drugs 0.000 description 2
• 229920000669 heparin Polymers 0.000 description 2
• 108010061175 high potential iron-sulfur protein Proteins 0.000 description 2
• 108700013236 human HMC Proteins 0.000 description 2
• 102000055536 human HMC Human genes 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000008105 immune reaction Effects 0.000 description 2
• 229940072221 immunoglobulins Drugs 0.000 description 2
• 208000015181 infectious disease Diseases 0.000 description 2
• 230000001524 infective effect Effects 0.000 description 2
• 229940028885 interleukin-4 Drugs 0.000 description 2
• 210000000936 intestine Anatomy 0.000 description 2
• 230000003834 intracellular effect Effects 0.000 description 2
• 238000001990 intravenous administration Methods 0.000 description 2
• PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 2
• JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 description 2
• JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 2
• YOBAEOGBNPPUQV-UHFFFAOYSA-N iron;trihydrate Chemical compound O.O.O.[Fe].[Fe] YOBAEOGBNPPUQV-UHFFFAOYSA-N 0.000 description 2
• 229960000310 isoleucine Drugs 0.000 description 2
• AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
• 238000012804 iterative process Methods 0.000 description 2
• 238000002372 labelling Methods 0.000 description 2
• 230000000670 limiting effect Effects 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 230000007774 longterm Effects 0.000 description 2
• 210000003712 lysosome Anatomy 0.000 description 2
• 230000001868 lysosomic effect Effects 0.000 description 2
• 230000014759 maintenance of location Effects 0.000 description 2
• 210000004962 mammalian cell Anatomy 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 238000005259 measurement Methods 0.000 description 2
• 229910021645 metal ion Inorganic materials 0.000 description 2
• 229930182817 methionine Natural products 0.000 description 2
• 239000000693 micelle Substances 0.000 description 2
• 239000003607 modifier Substances 0.000 description 2
• 108010068617 neonatal Fc receptor Proteins 0.000 description 2
• 239000002581 neurotoxin Substances 0.000 description 2
• 231100000618 neurotoxin Toxicity 0.000 description 2
• 238000003199 nucleic acid amplification method Methods 0.000 description 2
• 239000003921 oil Substances 0.000 description 2
• 235000019198 oils Nutrition 0.000 description 2
• 238000005457 optimization Methods 0.000 description 2
• 244000052769 pathogen Species 0.000 description 2
• 230000001717 pathogenic effect Effects 0.000 description 2
• 210000001322 periplasm Anatomy 0.000 description 2
• 108700010839 phage proteins Proteins 0.000 description 2
• COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
• 239000003016 pheromone Substances 0.000 description 2
• 229910052698 phosphorus Inorganic materials 0.000 description 2
• 229940127126 plasminogen activator Drugs 0.000 description 2
• 238000007747 plating Methods 0.000 description 2
• 238000011176 pooling Methods 0.000 description 2
• 229910052700 potassium Inorganic materials 0.000 description 2
• 239000000843 powder Substances 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 230000000069 prophylactic effect Effects 0.000 description 2
• 231100000654 protein toxin Toxicity 0.000 description 2
• 230000017854 proteolysis Effects 0.000 description 2
• 230000003252 repetitive effect Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 238000002702 ribosome display Methods 0.000 description 2
• 239000002795 scorpion venom Substances 0.000 description 2
• 238000002864 sequence alignment Methods 0.000 description 2
• 108010059841 serine carboxypeptidase Proteins 0.000 description 2
• 241000894007 species Species 0.000 description 2
• 239000003381 stabilizer Substances 0.000 description 2
• 238000007920 subcutaneous administration Methods 0.000 description 2
• 239000001797 sucrose acetate isobutyrate Substances 0.000 description 2
• 235000010983 sucrose acetate isobutyrate Nutrition 0.000 description 2
• UVGUPMLLGBCFEJ-SWTLDUCYSA-N sucrose acetate isobutyrate Chemical compound CC(C)C(=O)O[C@H]1[C@H](OC(=O)C(C)C)[C@@H](COC(=O)C(C)C)O[C@@]1(COC(C)=O)O[C@@H]1[C@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)[C@H](OC(=O)C(C)C)[C@@H](COC(C)=O)O1 UVGUPMLLGBCFEJ-SWTLDUCYSA-N 0.000 description 2
• 239000003774 sulfhydryl reagent Substances 0.000 description 2
• 230000002194 synthesizing effect Effects 0.000 description 2
• 125000003396 thiol group Chemical group [H]S* 0.000 description 2
• 230000000699 topical effect Effects 0.000 description 2
• 231100000331 toxic Toxicity 0.000 description 2
• 230000002588 toxic effect Effects 0.000 description 2
• 108010056110 toxin FS2 Proteins 0.000 description 2
• 230000031998 transcytosis Effects 0.000 description 2
• 238000013519 translation Methods 0.000 description 2
• 239000013638 trimer Substances 0.000 description 2
• 125000000430 tryptophan group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12 0.000 description 2
• 102000003298 tumor necrosis factor receptor Human genes 0.000 description 2
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
• 108020005087 unfolded proteins Proteins 0.000 description 2
• 229960005486 vaccine Drugs 0.000 description 2
• 239000004474 valine Substances 0.000 description 2
• 230000003612 virological effect Effects 0.000 description 2
• DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
• NMWKYTGJWUAZPZ-WWHBDHEGSA-N (4S)-4-[[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-2-[[(1R,6R,9S,12S,18S,21S,24S,27S,30S,33S,36S,39S,42R,47R,53S,56S,59S,62S,65S,68S,71S,76S,79S,85S)-47-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-3-carboxypropanoyl]amino]-18-(4-aminobutyl)-27,68-bis(3-amino-3-oxopropyl)-36,71,76-tribenzyl-39-(3-carbamimidamidopropyl)-24-(2-carboxyethyl)-21,56-bis(carboxymethyl)-65,85-bis[(1R)-1-hydroxyethyl]-59-(hydroxymethyl)-62,79-bis(1H-imidazol-4-ylmethyl)-9-methyl-33-(2-methylpropyl)-8,11,17,20,23,26,29,32,35,38,41,48,54,57,60,63,66,69,72,74,77,80,83,86-tetracosaoxo-30-propan-2-yl-3,4,44,45-tetrathia-7,10,16,19,22,25,28,31,34,37,40,49,55,58,61,64,67,70,73,75,78,81,84,87-tetracosazatetracyclo[40.31.14.012,16.049,53]heptaoctacontane-6-carbonyl]amino]-3-methylbutanoyl]amino]-7-(3-carbamimidamidopropyl)-25-(hydroxymethyl)-19-[(4-hydroxyphenyl)methyl]-28-(1H-imidazol-4-ylmethyl)-10-methyl-6,9,12,15,18,21,24,27,30-nonaoxo-16-propan-2-yl-1,2-dithia-5,8,11,14,17,20,23,26,29-nonazacyclodotriacontane-4-carbonyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-3-carboxy-1-[[(2S)-1-[[(2S)-1-[[(1S)-1-carboxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid Chemical compound CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](NC(=O)[C@@H]2CSSC[C@@H]3NC(=O)[C@H](Cc4ccccc4)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CSSC[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc4c[nH]cn4)NC(=O)[C@H](Cc4ccccc4)NC3=O)[C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C)C(=O)N2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)C(C)C)C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1)C(=O)N[C@@H](C)C(O)=O NMWKYTGJWUAZPZ-WWHBDHEGSA-N 0.000 description 1
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
• XLBBKEHLEPNMMF-SSUNCQRMSA-N 129038-42-2 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CS)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)[C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O)C1=CC=CC=C1 XLBBKEHLEPNMMF-SSUNCQRMSA-N 0.000 description 1
• GFRHEOMWAJJZSF-UHFFFAOYSA-N 2-[bis(2-chloroethyl)amino]-2-[4-[4-[1-[bis(2-chloroethyl)amino]-2-oxoethyl]phenyl]phenyl]acetaldehyde Chemical compound C1=CC(C(C=O)N(CCCl)CCCl)=CC=C1C1=CC=C(C(C=O)N(CCCl)CCCl)C=C1 GFRHEOMWAJJZSF-UHFFFAOYSA-N 0.000 description 1
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 1
• KIUMMUBSPKGMOY-UHFFFAOYSA-N 3,3'-Dithiobis(6-nitrobenzoic acid) Chemical compound C1=C([N+]([O-])=O)C(C(=O)O)=CC(SSC=2C=C(C(=CC=2)[N+]([O-])=O)C(O)=O)=C1 KIUMMUBSPKGMOY-UHFFFAOYSA-N 0.000 description 1
• 108010082808 4-1BB Ligand Proteins 0.000 description 1
• LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 description 1
• 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
• UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
• 102100022048 60S ribosomal protein L36 Human genes 0.000 description 1
• 101710187872 60S ribosomal protein L36 Proteins 0.000 description 1
• 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
• 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
• 102000007566 ATP-Dependent Proteases Human genes 0.000 description 1
• 108010071550 ATP-Dependent Proteases Proteins 0.000 description 1
• 101100295756 Acinetobacter baumannii (strain ATCC 19606 / DSM 30007 / JCM 6841 / CCUG 19606 / CIP 70.34 / NBRC 109757 / NCIMB 12457 / NCTC 12156 / 81) omp38 gene Proteins 0.000 description 1
• 108010075348 Activated-Leukocyte Cell Adhesion Molecule Proteins 0.000 description 1
• ORILYTVJVMAKLC-UHFFFAOYSA-N Adamantane Natural products C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
• 102100031786 Adiponectin Human genes 0.000 description 1
• 108010076365 Adiponectin Proteins 0.000 description 1
• 229920001817 Agar Polymers 0.000 description 1
• 229920000936 Agarose Polymers 0.000 description 1
• 101710186708 Agglutinin Proteins 0.000 description 1
• 102000054930 Agouti-Related Human genes 0.000 description 1
• 101710127426 Agouti-related protein Proteins 0.000 description 1
• 108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 1
• 101710150365 Albumin-1 Proteins 0.000 description 1
• 102000009027 Albumins Human genes 0.000 description 1
• 108010088751 Albumins Proteins 0.000 description 1
• 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
• 101710171801 Alpha-amylase inhibitor Proteins 0.000 description 1
• 101710092462 Alpha-hemolysin Proteins 0.000 description 1
• 101710197219 Alpha-toxin Proteins 0.000 description 1
• 208000024827 Alzheimer disease Diseases 0.000 description 1
• 244000153158 Ammi visnaga Species 0.000 description 1
• 235000010585 Ammi visnaga Nutrition 0.000 description 1
• 102100038778 Amphiregulin Human genes 0.000 description 1
• 108010033760 Amphiregulin Proteins 0.000 description 1
• 102000013142 Amylases Human genes 0.000 description 1
• 108010065511 Amylases Proteins 0.000 description 1
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
• 101000640208 Androctonus australis Alpha-mammal toxin Aah3 Proteins 0.000 description 1
• 241001083548 Anemone Species 0.000 description 1
• 101000642691 Anemonia sulcata Delta-actitoxin-Avd2a Proteins 0.000 description 1
• 102100022987 Angiogenin Human genes 0.000 description 1
• 102000004121 Annexin A5 Human genes 0.000 description 1
• 108090000672 Annexin A5 Proteins 0.000 description 1
• 101710083587 Antifungal protein Proteins 0.000 description 1
• 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
• 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
• 102100021569 Apoptosis regulator Bcl-2 Human genes 0.000 description 1
• 102000000443 Apple domains Human genes 0.000 description 1
• 108050008958 Apple domains Proteins 0.000 description 1
• 101001007348 Arachis hypogaea Galactose-binding lectin Proteins 0.000 description 1
• 101000939689 Araneus ventricosus U2-aranetoxin-Av1a Proteins 0.000 description 1
• 241000203069 Archaea Species 0.000 description 1
• DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
• 241000228212 Aspergillus Species 0.000 description 1
• 108010028006 B-Cell Activating Factor Proteins 0.000 description 1
• 108010046304 B-Cell Activation Factor Receptor Proteins 0.000 description 1
• 102000007536 B-Cell Activation Factor Receptor Human genes 0.000 description 1
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 description 1
• 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 description 1
• 241000193830 Bacillus <bacterium> Species 0.000 description 1
• 244000063299 Bacillus subtilis Species 0.000 description 1
• 235000014469 Bacillus subtilis Nutrition 0.000 description 1
• 102100028239 Basal cell adhesion molecule Human genes 0.000 description 1
• 102100032305 Bcl-2 homologous antagonist/killer Human genes 0.000 description 1
• 102100026189 Beta-galactosidase Human genes 0.000 description 1
• 101710125089 Bindin Proteins 0.000 description 1
• 102000015081 Blood Coagulation Factors Human genes 0.000 description 1
• 101000912561 Bos taurus Fibrinogen gamma-B chain Proteins 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• 102000004219 Brain-derived neurotrophic factor Human genes 0.000 description 1
• 108090000715 Brain-derived neurotrophic factor Proteins 0.000 description 1
• 101710142965 Bromelain inhibitor Proteins 0.000 description 1
• 101710190711 Bubble protein Proteins 0.000 description 1
• 101000633673 Buthacus arenicola Beta-insect depressant toxin BaIT2 Proteins 0.000 description 1
• 101000640215 Buthus occitanus tunetanus Alpha-mammal toxin Bot3 Proteins 0.000 description 1
• 102100023702 C-C motif chemokine 13 Human genes 0.000 description 1
• 102100023705 C-C motif chemokine 14 Human genes 0.000 description 1
• 102100023703 C-C motif chemokine 15 Human genes 0.000 description 1
• 102100023700 C-C motif chemokine 16 Human genes 0.000 description 1
• 102100023701 C-C motif chemokine 18 Human genes 0.000 description 1
• 102100036842 C-C motif chemokine 19 Human genes 0.000 description 1
• 102100036848 C-C motif chemokine 20 Human genes 0.000 description 1
• 102100036846 C-C motif chemokine 21 Human genes 0.000 description 1
• 102100032367 C-C motif chemokine 5 Human genes 0.000 description 1
• 102100032366 C-C motif chemokine 7 Human genes 0.000 description 1
• 102100025248 C-X-C motif chemokine 10 Human genes 0.000 description 1
• 102100025279 C-X-C motif chemokine 11 Human genes 0.000 description 1
• 102100039396 C-X-C motif chemokine 16 Human genes 0.000 description 1
• 102100036170 C-X-C motif chemokine 9 Human genes 0.000 description 1
• 102100024217 CAMPATH-1 antigen Human genes 0.000 description 1
• 101150049756 CCL6 gene Proteins 0.000 description 1
• 102100024210 CD166 antigen Human genes 0.000 description 1
• 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 description 1
• 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 description 1
• 108010017987 CD30 Ligand Proteins 0.000 description 1
• 108010065524 CD52 Antigen Proteins 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 1
• 229940045513 CTLA4 antagonist Drugs 0.000 description 1
• 101100123850 Caenorhabditis elegans her-1 gene Proteins 0.000 description 1
• 101100243399 Caenorhabditis elegans pept-2 gene Proteins 0.000 description 1
• 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 description 1
• BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
• 101710203402 Carboxypeptidase A inhibitor Proteins 0.000 description 1
• 102000003670 Carboxypeptidase B Human genes 0.000 description 1
• 108090000087 Carboxypeptidase B Proteins 0.000 description 1
• 102100025975 Cathepsin G Human genes 0.000 description 1
• 108090000617 Cathepsin G Proteins 0.000 description 1
• 102400001321 Cathepsin L Human genes 0.000 description 1
• 108090000624 Cathepsin L Proteins 0.000 description 1
• 108090000613 Cathepsin S Proteins 0.000 description 1
• 102100035654 Cathepsin S Human genes 0.000 description 1
• 108010008885 Cellulose 1,4-beta-Cellobiosidase Proteins 0.000 description 1
• 101000654318 Centruroides noxius Beta-mammal toxin Cn2 Proteins 0.000 description 1
• 101000693940 Centruroides noxius Beta-toxin Cn7 Proteins 0.000 description 1
• 101000617114 Centruroides noxius Beta-toxin Cn9 Proteins 0.000 description 1
• 241001432959 Chernes Species 0.000 description 1
• 101001028695 Chironex fleckeri Toxin CfTX-2 Proteins 0.000 description 1
• 108010089335 Cholecystokinin A Receptor Proteins 0.000 description 1
• 102100034927 Cholecystokinin receptor type A Human genes 0.000 description 1
• 102100024539 Chymase Human genes 0.000 description 1
• 108090000227 Chymases Proteins 0.000 description 1
• 108090000317 Chymotrypsin Proteins 0.000 description 1
• 241001638933 Cochlicella barbara Species 0.000 description 1
• 108091026890 Coding region Proteins 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010078044 Complement C1r Proteins 0.000 description 1
• 108090000059 Complement factor D Proteins 0.000 description 1
• 102000003706 Complement factor D Human genes 0.000 description 1
• 240000004244 Cucurbita moschata Species 0.000 description 1
• 235000009854 Cucurbita moschata Nutrition 0.000 description 1
• 235000009852 Cucurbita pepo Nutrition 0.000 description 1
• 101000644356 Cyriopagopus schmidti U1-theraphotoxin-Hs1a Proteins 0.000 description 1
• 101000644364 Cyriopagopus schmidti U1-theraphotoxin-Hs1b Proteins 0.000 description 1
• 102000015833 Cystatin Human genes 0.000 description 1
• 102100028007 Cystatin-SA Human genes 0.000 description 1
• 101710144510 Cysteine proteinase inhibitor Proteins 0.000 description 1
• 108010025905 Cystine-Knot Miniproteins Proteins 0.000 description 1
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 description 1
• 102000012410 DNA Ligases Human genes 0.000 description 1
• 108010061982 DNA Ligases Proteins 0.000 description 1
• 102000004594 DNA Polymerase I Human genes 0.000 description 1
• 108010017826 DNA Polymerase I Proteins 0.000 description 1
• 238000000018 DNA microarray Methods 0.000 description 1
• 230000033616 DNA repair Effects 0.000 description 1
• 238000001712 DNA sequencing Methods 0.000 description 1
• 101710120434 Defensin MGD-1 Proteins 0.000 description 1
• 101710084146 Dendroaspin Proteins 0.000 description 1
• 101710128010 Di-/tripeptide transporter Proteins 0.000 description 1
• LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
• HJEINPVZRDJRBY-UHFFFAOYSA-N Disul Chemical compound OS(=O)(=O)OCCOC1=CC=C(Cl)C=C1Cl HJEINPVZRDJRBY-UHFFFAOYSA-N 0.000 description 1
• 102100029721 DnaJ homolog subfamily B member 1 Human genes 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 101100044298 Drosophila melanogaster fand gene Proteins 0.000 description 1
• 108010024212 E-Selectin Proteins 0.000 description 1
• 102100023471 E-selectin Human genes 0.000 description 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
• 102000001301 EGF receptor Human genes 0.000 description 1
• 108060006698 EGF receptor Proteins 0.000 description 1
• 238000012286 ELISA Assay Methods 0.000 description 1
• 101150029707 ERBB2 gene Proteins 0.000 description 1
• 102100025137 Early activation antigen CD69 Human genes 0.000 description 1
• 102100037354 Ectodysplasin-A Human genes 0.000 description 1
• 108010015972 Elafin Proteins 0.000 description 1
• 241000305071 Enterobacterales Species 0.000 description 1
• 101710181478 Envelope glycoprotein GP350 Proteins 0.000 description 1
• 108010062466 Enzyme Precursors Proteins 0.000 description 1
• 102000010911 Enzyme Precursors Human genes 0.000 description 1
• 101800000155 Epiregulin Proteins 0.000 description 1
• 241000672609 Escherichia coli BL21 Species 0.000 description 1
• 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
• 108700024394 Exon Proteins 0.000 description 1
• 101150081880 FGF1 gene Proteins 0.000 description 1
• 108010076282 Factor IX Proteins 0.000 description 1
• 108010054265 Factor VIIa Proteins 0.000 description 1
• 108010014173 Factor X Proteins 0.000 description 1
• 108010039471 Fas Ligand Protein Proteins 0.000 description 1
• 108010087819 Fc receptors Proteins 0.000 description 1
• 102000009109 Fc receptors Human genes 0.000 description 1
• 108010000916 Fimbriae Proteins Proteins 0.000 description 1
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
• 241000223218 Fusarium Species 0.000 description 1
• 101710160621 Fusion glycoprotein F0 Proteins 0.000 description 1
• 101150083125 GGCX gene Proteins 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 108010063907 Glutathione Reductase Proteins 0.000 description 1
• 102100036442 Glutathione reductase, mitochondrial Human genes 0.000 description 1
• BCCRXDTUTZHDEU-VKHMYHEASA-N Gly-Ser Chemical compound NCC(=O)N[C@@H](CO)C(O)=O BCCRXDTUTZHDEU-VKHMYHEASA-N 0.000 description 1
• 102000003886 Glycoproteins Human genes 0.000 description 1
• 108090000288 Glycoproteins Proteins 0.000 description 1
• 108010086677 Gonadotropins Proteins 0.000 description 1
• 102000006771 Gonadotropins Human genes 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102000009465 Growth Factor Receptors Human genes 0.000 description 1
• 108010009202 Growth Factor Receptors Proteins 0.000 description 1
• 102100020948 Growth hormone receptor Human genes 0.000 description 1
• 101710099093 Growth hormone receptor Proteins 0.000 description 1
• 101710093473 Gurmarin Proteins 0.000 description 1
• 101000918874 Gymnadenia conopsea Defensin-like protein Proteins 0.000 description 1
• 102000004447 HSP40 Heat-Shock Proteins Human genes 0.000 description 1
• 101000588273 Heteractis crispa Delta-stichotoxin-Hcr1a Proteins 0.000 description 1
• 241000545744 Hirudinea Species 0.000 description 1
• 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
• 101100118545 Holotrichia diomphalia EGF-like gene Proteins 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000971171 Homo sapiens Apoptosis regulator Bcl-2 Proteins 0.000 description 1
• 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 description 1
• 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 description 1
• 101100325746 Homo sapiens BAK1 gene Proteins 0.000 description 1
• 101000935638 Homo sapiens Basal cell adhesion molecule Proteins 0.000 description 1
• 101000766294 Homo sapiens Branched-chain-amino-acid aminotransferase, mitochondrial Proteins 0.000 description 1
• 101000978379 Homo sapiens C-C motif chemokine 13 Proteins 0.000 description 1
• 101000978381 Homo sapiens C-C motif chemokine 14 Proteins 0.000 description 1
• 101000978376 Homo sapiens C-C motif chemokine 15 Proteins 0.000 description 1
• 101000978375 Homo sapiens C-C motif chemokine 16 Proteins 0.000 description 1
• 101000978371 Homo sapiens C-C motif chemokine 18 Proteins 0.000 description 1
• 101000713106 Homo sapiens C-C motif chemokine 19 Proteins 0.000 description 1
• 101000713099 Homo sapiens C-C motif chemokine 20 Proteins 0.000 description 1
• 101000713085 Homo sapiens C-C motif chemokine 21 Proteins 0.000 description 1
• 101000797762 Homo sapiens C-C motif chemokine 5 Proteins 0.000 description 1
• 101000797758 Homo sapiens C-C motif chemokine 7 Proteins 0.000 description 1
• 101000858088 Homo sapiens C-X-C motif chemokine 10 Proteins 0.000 description 1
• 101000858060 Homo sapiens C-X-C motif chemokine 11 Proteins 0.000 description 1
• 101000889133 Homo sapiens C-X-C motif chemokine 16 Proteins 0.000 description 1
• 101000947172 Homo sapiens C-X-C motif chemokine 9 Proteins 0.000 description 1
• 101000934374 Homo sapiens Early activation antigen CD69 Proteins 0.000 description 1
• 101000880080 Homo sapiens Ectodysplasin-A Proteins 0.000 description 1
• 101001048718 Homo sapiens Elafin Proteins 0.000 description 1
• 101000746373 Homo sapiens Granulocyte-macrophage colony-stimulating factor Proteins 0.000 description 1
• 101001033279 Homo sapiens Interleukin-3 Proteins 0.000 description 1
• 101001055222 Homo sapiens Interleukin-8 Proteins 0.000 description 1
• 101000961414 Homo sapiens Membrane cofactor protein Proteins 0.000 description 1
• 101000979223 Homo sapiens N-terminal EF-hand calcium-binding protein 3 Proteins 0.000 description 1
• 101000589482 Homo sapiens Nuclear cap-binding protein subunit 2 Proteins 0.000 description 1
• 101000871708 Homo sapiens Proheparin-binding EGF-like growth factor Proteins 0.000 description 1
• 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
• 101000617130 Homo sapiens Stromal cell-derived factor 1 Proteins 0.000 description 1
• 101100537522 Homo sapiens TNFSF13B gene Proteins 0.000 description 1
• 101000775102 Homo sapiens Transcriptional coactivator YAP1 Proteins 0.000 description 1
• 101000830565 Homo sapiens Tumor necrosis factor ligand superfamily member 10 Proteins 0.000 description 1
• 101000830596 Homo sapiens Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
• 101000764263 Homo sapiens Tumor necrosis factor ligand superfamily member 4 Proteins 0.000 description 1
• 101000638161 Homo sapiens Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 101000638255 Homo sapiens Tumor necrosis factor ligand superfamily member 8 Proteins 0.000 description 1
• 101000638251 Homo sapiens Tumor necrosis factor ligand superfamily member 9 Proteins 0.000 description 1
• 101000798130 Homo sapiens Tumor necrosis factor receptor superfamily member 11B Proteins 0.000 description 1
• 101000795169 Homo sapiens Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 101000648507 Homo sapiens Tumor necrosis factor receptor superfamily member 14 Proteins 0.000 description 1
• 101000801254 Homo sapiens Tumor necrosis factor receptor superfamily member 16 Proteins 0.000 description 1
• 101000801255 Homo sapiens Tumor necrosis factor receptor superfamily member 17 Proteins 0.000 description 1
• 101000762805 Homo sapiens Tumor necrosis factor receptor superfamily member 19L Proteins 0.000 description 1
• 101000679907 Homo sapiens Tumor necrosis factor receptor superfamily member 27 Proteins 0.000 description 1
• 101000679857 Homo sapiens Tumor necrosis factor receptor superfamily member 3 Proteins 0.000 description 1
• 101000611185 Homo sapiens Tumor necrosis factor receptor superfamily member 5 Proteins 0.000 description 1
• 101000920026 Homo sapiens Tumor necrosis factor receptor superfamily member EDAR Proteins 0.000 description 1
• 101000808011 Homo sapiens Vascular endothelial growth factor A Proteins 0.000 description 1
• 101000873111 Homo sapiens Vesicle transport protein SEC20 Proteins 0.000 description 1
• 101710146024 Horcolin Proteins 0.000 description 1
• 108010070875 Human Immunodeficiency Virus tat Gene Products Proteins 0.000 description 1
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 102000004371 Insulin-like growth factor binding protein 5 Human genes 0.000 description 1
• 108090000961 Insulin-like growth factor binding protein 5 Proteins 0.000 description 1
• 108010050904 Interferons Proteins 0.000 description 1
• 102000014150 Interferons Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000172 Interleukin-15 Proteins 0.000 description 1
• 102000003812 Interleukin-15 Human genes 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102100039064 Interleukin-3 Human genes 0.000 description 1
• 102000000743 Interleukin-5 Human genes 0.000 description 1
• 108010002616 Interleukin-5 Proteins 0.000 description 1
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 1
• 102100026236 Interleukin-8 Human genes 0.000 description 1
• 101800003534 Kalata-B1 Proteins 0.000 description 1
• 102000001399 Kallikrein Human genes 0.000 description 1
• 108060005987 Kallikrein Proteins 0.000 description 1
• 101710177504 Kit ligand Proteins 0.000 description 1
• 241000235649 Kluyveromyces Species 0.000 description 1
• ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
• DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
• LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
• ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
• HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
• AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
• 108010001831 LDL receptors Proteins 0.000 description 1
• 108010054278 Lac Repressors Proteins 0.000 description 1
• 101710189395 Lectin Proteins 0.000 description 1
• 102000004856 Lectins Human genes 0.000 description 1
• 108090001090 Lectins Proteins 0.000 description 1
• 102000003960 Ligases Human genes 0.000 description 1
• 108090000364 Ligases Proteins 0.000 description 1
• 102000010954 Link domains Human genes 0.000 description 1
• 108050001157 Link domains Proteins 0.000 description 1
• 102100024640 Low-density lipoprotein receptor Human genes 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 102000043129 MHC class I family Human genes 0.000 description 1
• 108091054437 MHC class I family Proteins 0.000 description 1
• 102220548557 Macrophage-capping protein_V41I_mutation Human genes 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 102100026046 Mannan-binding lectin serine protease 2 Human genes 0.000 description 1
• 101710117460 Mannan-binding lectin serine protease 2 Proteins 0.000 description 1
• 101710179758 Mannose-specific lectin Proteins 0.000 description 1
• 101710150763 Mannose-specific lectin 1 Proteins 0.000 description 1
• 101710150745 Mannose-specific lectin 2 Proteins 0.000 description 1
• 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 description 1
• 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
• 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
• 102100039373 Membrane cofactor protein Human genes 0.000 description 1
• 101000694034 Mesobuthus martensii Putative potassium channel blocker TXKS1 Proteins 0.000 description 1
• 108030000089 Metallocarboxypeptidases Proteins 0.000 description 1
• 102000006166 Metallocarboxypeptidases Human genes 0.000 description 1
• 102000003792 Metallothionein Human genes 0.000 description 1
• 108090000157 Metallothionein Proteins 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 241000237852 Mollusca Species 0.000 description 1
• 101710086426 Myotoxin Proteins 0.000 description 1
• 102100023213 N-terminal EF-hand calcium-binding protein 3 Human genes 0.000 description 1
• 125000000729 N-terminal amino-acid group Chemical group 0.000 description 1
• 101000822882 Naja atra Cobrotoxin Proteins 0.000 description 1
• 101000675421 Naja mossambica Short neurotoxin 3 Proteins 0.000 description 1
• 101710148436 Nawaprin Proteins 0.000 description 1
• 241000588653 Neisseria Species 0.000 description 1
• 108700019961 Neoplasm Genes Proteins 0.000 description 1
• 102000048850 Neoplasm Genes Human genes 0.000 description 1
• 102000007072 Nerve Growth Factors Human genes 0.000 description 1
• 101710204471 Neurotoxin B-IV Proteins 0.000 description 1
• 102100037369 Nidogen-1 Human genes 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 239000004677 Nylon Substances 0.000 description 1
• 108010042215 OX40 Ligand Proteins 0.000 description 1
• 102000015636 Oligopeptides Human genes 0.000 description 1
• 108010038807 Oligopeptides Proteins 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 101710202270 Oryzain beta chain Proteins 0.000 description 1
• 102100040557 Osteopontin Human genes 0.000 description 1
• 108010081689 Osteopontin Proteins 0.000 description 1
• 108010035042 Osteoprotegerin Proteins 0.000 description 1
• 108010035766 P-Selectin Proteins 0.000 description 1
• 102100023472 P-selectin Human genes 0.000 description 1
• 238000012408 PCR amplification Methods 0.000 description 1
• 101150030083 PE38 gene Proteins 0.000 description 1
• 108010067372 Pancreatic elastase Proteins 0.000 description 1
• 102000016387 Pancreatic elastase Human genes 0.000 description 1
• 101001049890 Pandinus imperator Potassium channel toxin alpha-KTx 6.5 Proteins 0.000 description 1
• 108090000526 Papain Proteins 0.000 description 1
• 241000223785 Paramecium Species 0.000 description 1
• 102000057297 Pepsin A Human genes 0.000 description 1
• 108090000284 Pepsin A Proteins 0.000 description 1
• 102000007079 Peptide Fragments Human genes 0.000 description 1
• 108010033276 Peptide Fragments Proteins 0.000 description 1
• 108010067902 Peptide Library Proteins 0.000 description 1
• 102100032393 Peptidoglycan recognition protein 1 Human genes 0.000 description 1
• 101710113134 Peptidoglycan recognition protein 1 Proteins 0.000 description 1
• 101710124951 Phospholipase C Proteins 0.000 description 1
• 101001125135 Phytophthora capsici NLP effector protein 1 Proteins 0.000 description 1
• 108010089814 Plant Lectins Proteins 0.000 description 1
• 108010064851 Plant Proteins Proteins 0.000 description 1
• 102100038124 Plasminogen Human genes 0.000 description 1
• 241000224016 Plasmodium Species 0.000 description 1
• 101001037768 Plasmodium berghei 58 kDa phosphoprotein Proteins 0.000 description 1
• 101100335198 Pneumocystis carinii fol1 gene Proteins 0.000 description 1
• 229920002732 Polyanhydride Polymers 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 1
• 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 102100025498 Proepiregulin Human genes 0.000 description 1
• 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 1
• 108010049395 Prokaryotic Initiation Factor-2 Proteins 0.000 description 1
• 102100038277 Prostaglandin G/H synthase 1 Human genes 0.000 description 1
• 108050003243 Prostaglandin G/H synthase 1 Proteins 0.000 description 1
• 101800004937 Protein C Proteins 0.000 description 1
• 101710150593 Protein beta Proteins 0.000 description 1
• 102100032350 Protransforming growth factor alpha Human genes 0.000 description 1
• 101000762949 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Exotoxin A Proteins 0.000 description 1
• 101150094745 Ptk2b gene Proteins 0.000 description 1
• 102000018795 RELT Human genes 0.000 description 1
• 108010052562 RELT Proteins 0.000 description 1
• 241000700159 Rattus Species 0.000 description 1
• 108010038036 Receptor Activator of Nuclear Factor-kappa B Proteins 0.000 description 1
• 102000010498 Receptor Activator of Nuclear Factor-kappa B Human genes 0.000 description 1
• 102000004278 Receptor Protein-Tyrosine Kinases Human genes 0.000 description 1
• 108090000873 Receptor Protein-Tyrosine Kinases Proteins 0.000 description 1
• 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
• 108020004511 Recombinant DNA Proteins 0.000 description 1
• 108700008625 Reporter Genes Proteins 0.000 description 1
• 102100024735 Resistin Human genes 0.000 description 1
• 108010047909 Resistin Proteins 0.000 description 1
• 108010041388 Ribonucleotide Reductases Proteins 0.000 description 1
• 102000000505 Ribonucleotide Reductases Human genes 0.000 description 1
• 241000235070 Saccharomyces Species 0.000 description 1
• 102400000827 Saposin-D Human genes 0.000 description 1
• 101800001700 Saposin-D Proteins 0.000 description 1
• 108091058545 Secretory proteins Proteins 0.000 description 1
• 102000040739 Secretory proteins Human genes 0.000 description 1
• 238000012300 Sequence Analysis Methods 0.000 description 1
• 102100034136 Serine/threonine-protein kinase receptor R3 Human genes 0.000 description 1
• 101710082813 Serine/threonine-protein kinase receptor R3 Proteins 0.000 description 1
• 108050000761 Serpin Proteins 0.000 description 1
• 102000008847 Serpin Human genes 0.000 description 1
• 108010034546 Serratia marcescens nuclease Proteins 0.000 description 1
• 108010029157 Sialic Acid Binding Ig-like Lectin 2 Proteins 0.000 description 1
• 102000000890 Somatomedin B domains Human genes 0.000 description 1
• 108050007913 Somatomedin B domains Proteins 0.000 description 1
• 102000004584 Somatomedin Receptors Human genes 0.000 description 1
• 108010017622 Somatomedin Receptors Proteins 0.000 description 1
• 101800004225 Somatomedin-B Proteins 0.000 description 1
• 102100021669 Stromal cell-derived factor 1 Human genes 0.000 description 1
• 108700005078 Synthetic Genes Proteins 0.000 description 1
• 108091008874 T cell receptors Proteins 0.000 description 1
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
• 108700012920 TNF Proteins 0.000 description 1
• 108091007178 TNFRSF10A Proteins 0.000 description 1
• 206010043376 Tetanus Diseases 0.000 description 1
• 102000002933 Thioredoxin Human genes 0.000 description 1
• 102000013090 Thioredoxin-Disulfide Reductase Human genes 0.000 description 1
• 108010079911 Thioredoxin-disulfide reductase Proteins 0.000 description 1
• AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
• 239000004473 Threonine Substances 0.000 description 1
• 108090000190 Thrombin Proteins 0.000 description 1
• 102100026966 Thrombomodulin Human genes 0.000 description 1
• 108010079274 Thrombomodulin Proteins 0.000 description 1
• 102100034196 Thrombopoietin receptor Human genes 0.000 description 1
• 101710148535 Thrombopoietin receptor Proteins 0.000 description 1
• 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 1
• 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 1
• 108050006955 Tissue-type plasminogen activator Proteins 0.000 description 1
• 102100033571 Tissue-type plasminogen activator Human genes 0.000 description 1
• 102000002689 Toll-like receptor Human genes 0.000 description 1
• 108020000411 Toll-like receptor Proteins 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 102000040945 Transcription factor Human genes 0.000 description 1
• 102100031873 Transcriptional coactivator YAP1 Human genes 0.000 description 1
• 108020004566 Transfer RNA Proteins 0.000 description 1
• 102000004338 Transferrin Human genes 0.000 description 1
• 108090000901 Transferrin Proteins 0.000 description 1
• 101800004564 Transforming growth factor alpha Proteins 0.000 description 1
• 102000001400 Tryptase Human genes 0.000 description 1
• 108060005989 Tryptase Proteins 0.000 description 1
• 102000012883 Tumor Necrosis Factor Ligand Superfamily Member 14 Human genes 0.000 description 1
• 108010065158 Tumor Necrosis Factor Ligand Superfamily Member 14 Proteins 0.000 description 1
• 108090000138 Tumor necrosis factor ligand superfamily member 15 Proteins 0.000 description 1
• 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 1
• 101710178300 Tumor necrosis factor receptor superfamily member 13C Proteins 0.000 description 1
• 102100033725 Tumor necrosis factor receptor superfamily member 16 Human genes 0.000 description 1
• 102100026716 Tumor necrosis factor receptor superfamily member 19L Human genes 0.000 description 1
• 102100033733 Tumor necrosis factor receptor superfamily member 1B Human genes 0.000 description 1
• 101710187830 Tumor necrosis factor receptor superfamily member 1B Proteins 0.000 description 1
• 102100022202 Tumor necrosis factor receptor superfamily member 27 Human genes 0.000 description 1
• 102100022156 Tumor necrosis factor receptor superfamily member 3 Human genes 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 102100030810 Tumor necrosis factor receptor superfamily member EDAR Human genes 0.000 description 1
• 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
• 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
• 206010046865 Vaccinia virus infection Diseases 0.000 description 1
• 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
• 241000700605 Viruses Species 0.000 description 1
• 102100029477 Vitamin K-dependent protein C Human genes 0.000 description 1
• 101710193900 Vitamin K-dependent protein C Proteins 0.000 description 1
• 108010031318 Vitronectin Proteins 0.000 description 1
• 238000002835 absorbance Methods 0.000 description 1
• 230000021736 acetylation Effects 0.000 description 1
• 238000006640 acetylation reaction Methods 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 239000002671 adjuvant Substances 0.000 description 1
• 239000008272 agar Substances 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 239000000910 agglutinin Substances 0.000 description 1
• 230000004931 aggregating effect Effects 0.000 description 1
• 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000000217 alkyl group Chemical group 0.000 description 1
• 230000008848 allosteric regulation Effects 0.000 description 1
• 238000003016 alphascreen Methods 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 235000019418 amylase Nutrition 0.000 description 1
• 239000003392 amylase inhibitor Substances 0.000 description 1
• 229940025131 amylases Drugs 0.000 description 1
• 230000033115 angiogenesis Effects 0.000 description 1
• 108010072788 angiogenin Proteins 0.000 description 1
• 210000004102 animal cell Anatomy 0.000 description 1
• 230000001194 anti-hemostatic effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 230000002303 anti-venom Effects 0.000 description 1
• 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 239000003125 aqueous solvent Substances 0.000 description 1
• 101150042295 arfA gene Proteins 0.000 description 1
• 238000000149 argon plasma sintering Methods 0.000 description 1
• 229960001230 asparagine Drugs 0.000 description 1
• 235000009582 asparagine Nutrition 0.000 description 1
• QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
• 238000000376 autoradiography Methods 0.000 description 1
• 108010005774 beta-Galactosidase Proteins 0.000 description 1
• 125000002619 bicyclic group Chemical group 0.000 description 1
• 239000002981 blocking agent Substances 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 230000023555 blood coagulation Effects 0.000 description 1
• 239000003114 blood coagulation factor Substances 0.000 description 1
• 239000003130 blood coagulation factor inhibitor Substances 0.000 description 1
• 238000009835 boiling Methods 0.000 description 1
• 239000006227 byproduct Substances 0.000 description 1
• 210000004900 c-terminal fragment Anatomy 0.000 description 1
• 229910052793 cadmium Inorganic materials 0.000 description 1
• 238000004364 calculation method Methods 0.000 description 1
• 201000011510 cancer Diseases 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• 239000004202 carbamide Substances 0.000 description 1
• 235000011089 carbon dioxide Nutrition 0.000 description 1
• 108010079058 casein hydrolysate Proteins 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 239000013592 cell lysate Substances 0.000 description 1
• 230000006037 cell lysis Effects 0.000 description 1
• 230000030570 cellular localization Effects 0.000 description 1
• OEDKDVKQFDPTHK-UBIDWWFKSA-N chembl526148 Chemical compound C([C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H]2C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@H]3CSSC[C@H]4C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@H](C(N1)=O)CSSC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC=1C5=CC=CC=C5NC=1)NC(=O)[C@H](C(C)C)NC3=O)C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CSSC2)C(=O)N[C@@H](CO)C(=O)N4)=O)[C@@H](C)CC)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 OEDKDVKQFDPTHK-UBIDWWFKSA-N 0.000 description 1
• 238000010382 chemical cross-linking Methods 0.000 description 1
• 102000021178 chitin binding proteins Human genes 0.000 description 1
• 108091011157 chitin binding proteins Proteins 0.000 description 1
• 229960002376 chymotrypsin Drugs 0.000 description 1
• 108010014869 circulin A Proteins 0.000 description 1
• 239000007979 citrate buffer Substances 0.000 description 1
• 238000003776 cleavage reaction Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 238000004590 computer program Methods 0.000 description 1
• 238000005094 computer simulation Methods 0.000 description 1
• 235000008504 concentrate Nutrition 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• 238000007796 conventional method Methods 0.000 description 1
• BPLKXBNWXRMHRE-UHFFFAOYSA-N copper;1,10-phenanthroline Chemical compound [Cu].C1=CN=C2C3=NC=CC=C3C=CC2=C1 BPLKXBNWXRMHRE-UHFFFAOYSA-N 0.000 description 1
• 230000037029 cross reaction Effects 0.000 description 1
• 238000002425 crystallisation Methods 0.000 description 1
• 230000008025 crystallization Effects 0.000 description 1
• 239000012228 culture supernatant Substances 0.000 description 1
• 108050004038 cystatin Proteins 0.000 description 1
• 239000002852 cysteine proteinase inhibitor Substances 0.000 description 1
• 229960003067 cystine Drugs 0.000 description 1
• 231100000433 cytotoxic Toxicity 0.000 description 1
• 230000001472 cytotoxic effect Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 230000007547 defect Effects 0.000 description 1
• 230000002950 deficient Effects 0.000 description 1
• 239000007857 degradation product Substances 0.000 description 1
• 230000002939 deleterious effect Effects 0.000 description 1
• 238000002716 delivery method Methods 0.000 description 1
• 239000003398 denaturant Substances 0.000 description 1
• 238000004925 denaturation Methods 0.000 description 1
• 230000036425 denaturation Effects 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 238000000502 dialysis Methods 0.000 description 1
• 230000004069 differentiation Effects 0.000 description 1
• LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
• 229960005156 digoxin Drugs 0.000 description 1
• LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000006471 dimerization reaction Methods 0.000 description 1
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
• 239000012153 distilled water Substances 0.000 description 1
• 238000001647 drug administration Methods 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 230000036267 drug metabolism Effects 0.000 description 1
• 239000003596 drug target Substances 0.000 description 1
• 230000009977 dual effect Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 108010025752 echistatin Proteins 0.000 description 1
• MDCUNMLZLNGCQA-HWOAGHQOSA-N elafin Chemical compound N([C@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H]1C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H]2CSSC[C@H]3C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N[C@@H](CSSC[C@H]4C(=O)N5CCC[C@H]5C(=O)NCC(=O)N[C@H](C(N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]5N(CCC5)C(=O)[C@H]5N(CCC5)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC2=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N4)C(=O)N[C@@H](CSSC1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N3)=O)[C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)C(C)C)C(C)C)C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)N MDCUNMLZLNGCQA-HWOAGHQOSA-N 0.000 description 1
• 210000002889 endothelial cell Anatomy 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 239000000147 enterotoxin Substances 0.000 description 1
• 231100000655 enterotoxin Toxicity 0.000 description 1
• 238000003174 enzyme fragment complementation Methods 0.000 description 1
• 102000012803 ephrin Human genes 0.000 description 1
• 108060002566 ephrin Proteins 0.000 description 1
• 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 1
• 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• QGWYLXFVPIMLDO-UHFFFAOYSA-N ethyl n-[4-[benzyl(2-phenylethyl)amino]-2-(2,4,5-trimethoxyphenyl)-1h-imidazo[4,5-c]pyridin-6-yl]carbamate Chemical compound N=1C(NC(=O)OCC)=CC=2NC(C=3C(=CC(OC)=C(OC)C=3)OC)=NC=2C=1N(CC=1C=CC=CC=1)CCC1=CC=CC=C1 QGWYLXFVPIMLDO-UHFFFAOYSA-N 0.000 description 1
• 230000005496 eutectics Effects 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 230000029142 excretion Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 229940012414 factor viia Drugs 0.000 description 1
• 235000013861 fat-free Nutrition 0.000 description 1
• 102000013370 fibrillin Human genes 0.000 description 1
• 108060002895 fibrillin Proteins 0.000 description 1
• 238000011049 filling Methods 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 108091006047 fluorescent proteins Proteins 0.000 description 1
• 102000034287 fluorescent proteins Human genes 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 235000013373 food additive Nutrition 0.000 description 1
• 239000002778 food additive Substances 0.000 description 1
• 238000013467 fragmentation Methods 0.000 description 1
• 238000006062 fragmentation reaction Methods 0.000 description 1
• 230000005714 functional activity Effects 0.000 description 1
• 125000000524 functional group Chemical group 0.000 description 1
• 102000013069 gamma-Crystallins Human genes 0.000 description 1
• 108010079934 gamma-Crystallins Proteins 0.000 description 1
• 230000006251 gamma-carboxylation Effects 0.000 description 1
• 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
• 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
• 239000003862 glucocorticoid Substances 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
• 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
• 239000002622 gonadotropin Substances 0.000 description 1
• 210000002443 helper t lymphocyte Anatomy 0.000 description 1
• 208000006454 hepatitis Diseases 0.000 description 1
• 231100000283 hepatitis Toxicity 0.000 description 1
• 108010034429 heregulin alpha Proteins 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 108091008039 hormone receptors Proteins 0.000 description 1
• 102000055691 human APC Human genes 0.000 description 1
• 102000058223 human VEGFA Human genes 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 239000000017 hydrogel Substances 0.000 description 1
• 210000001822 immobilized cell Anatomy 0.000 description 1
• 230000028993 immune response Effects 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 238000003018 immunoassay Methods 0.000 description 1
• 239000007943 implant Substances 0.000 description 1
• 238000000126 in silico method Methods 0.000 description 1
• 238000010348 incorporation Methods 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000002458 infectious effect Effects 0.000 description 1
• 238000002664 inhalation therapy Methods 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000011081 inoculation Methods 0.000 description 1
• 230000002608 insulinlike Effects 0.000 description 1
• 229940079322 interferon Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 108040006849 interleukin-2 receptor activity proteins Proteins 0.000 description 1
• 108040006858 interleukin-6 receptor activity proteins Proteins 0.000 description 1
• 238000007918 intramuscular administration Methods 0.000 description 1
• 238000007912 intraperitoneal administration Methods 0.000 description 1
• 238000007913 intrathecal administration Methods 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 229910052742 iron Inorganic materials 0.000 description 1
• 108010059557 kistrin Proteins 0.000 description 1
• 101150066555 lacZ gene Proteins 0.000 description 1
• 239000002523 lectin Substances 0.000 description 1
• 231100000518 lethal Toxicity 0.000 description 1
• 230000001665 lethal effect Effects 0.000 description 1
• 210000000265 leukocyte Anatomy 0.000 description 1
• 230000029226 lipidation Effects 0.000 description 1
• 239000007791 liquid phase Substances 0.000 description 1
• 239000007937 lozenge Substances 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 230000002132 lysosomal effect Effects 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
• 210000003936 merozoite Anatomy 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 150000002739 metals Chemical class 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• 108010036691 methylamine dehydrogenase Proteins 0.000 description 1
• 235000013336 milk Nutrition 0.000 description 1
• 239000008267 milk Substances 0.000 description 1
• 210000004080 milk Anatomy 0.000 description 1
• 230000003278 mimic effect Effects 0.000 description 1
• 239000003226 mitogen Substances 0.000 description 1
• 238000002156 mixing Methods 0.000 description 1
• 238000010369 molecular cloning Methods 0.000 description 1
• 238000003032 molecular docking Methods 0.000 description 1
• 125000002950 monocyclic group Chemical group 0.000 description 1
• 210000001616 monocyte Anatomy 0.000 description 1
• 230000036438 mutation frequency Effects 0.000 description 1
• KJNFMGMNZKFGIE-UHFFFAOYSA-N n-(4-hydroxyphenyl)acetamide;5-(2-methylpropyl)-5-prop-2-enyl-1,3-diazinane-2,4,6-trione;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)NC1=CC=C(O)C=C1.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O KJNFMGMNZKFGIE-UHFFFAOYSA-N 0.000 description 1
• YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 1
• SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
• 239000002077 nanosphere Substances 0.000 description 1
• 230000009826 neoplastic cell growth Effects 0.000 description 1
• 208000015122 neurodegenerative disease Diseases 0.000 description 1
• 108010008217 nidogen Proteins 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 108700007229 noggin Proteins 0.000 description 1
• 102000045246 noggin Human genes 0.000 description 1
• 230000009871 nonspecific binding Effects 0.000 description 1
• 210000001331 nose Anatomy 0.000 description 1
• 210000004940 nucleus Anatomy 0.000 description 1
• 229920001778 nylon Polymers 0.000 description 1
• XXWNADNJWWLFFP-UHFFFAOYSA-N obtustatin Chemical compound C=1C=C(O)C=CC=1CC(C(=O)N1C(CCC1)C(=O)NCC(O)=O)NC(=O)C(CC(C)C)NC(=O)C1CCCN1C(=O)C(NC(=O)C(CC(O)=O)NC(=O)C(CSSCC(NC1=O)C(=O)NC(CCCNC(N)=N)C(=O)NC(CCC(N)=O)C(=O)N2)NC(=O)C(CO)NC(=O)C(CCCCN)NC(=O)CNC(=O)C(C(C)O)NC3=O)CSSCC(C(NC(CC=4C5=CC=CC=C5NC=4)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NC(C(=O)NC(CO)C(=O)NC(CC=4N=CNC=4)C(=O)N4)C(C)O)C(C)O)=O)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)CNC(=O)C(C)NC(=O)C5CCCN5C(=O)C(CCCCN)NC(=O)C(CC(C)C)NC(=O)C(CCCCN)NC(=O)C2CSSCC(N)C(=O)NC(C(C)O)C(=O)NC(C(C)O)C(=O)NCC(=O)N2CCCC2C(=O)NC1CSSCC3NC(=O)C4CC1=CC=C(O)C=C1 XXWNADNJWWLFFP-UHFFFAOYSA-N 0.000 description 1
• XXUPLYBCNPLTIW-UHFFFAOYSA-N octadec-7-ynoic acid Chemical compound CCCCCCCCCCC#CCCCCCC(O)=O XXUPLYBCNPLTIW-UHFFFAOYSA-N 0.000 description 1
• 101150087557 omcB gene Proteins 0.000 description 1
• 101150115693 ompA gene Proteins 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 229940126701 oral medication Drugs 0.000 description 1
• YPZRWBKMTBYPTK-UHFFFAOYSA-N oxidized gamma-L-glutamyl-L-cysteinylglycine Natural products OC(=O)C(N)CCC(=O)NC(C(=O)NCC(O)=O)CSSCC(C(=O)NCC(O)=O)NC(=O)CCC(N)C(O)=O YPZRWBKMTBYPTK-UHFFFAOYSA-N 0.000 description 1
• 229910052760 oxygen Inorganic materials 0.000 description 1
• 239000001301 oxygen Substances 0.000 description 1
• CFRTULIKXDWFLG-AGMMIYIUSA-N palicourein Chemical compound C([C@H]1C(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@H](C(=O)N[C@H]4CSSC[C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC2=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N[C@H](C(N2CCC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(O)=O)NC4=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N3)C(C)C)=O)[C@@H](C)CC)C(C)C)[C@@H](C)O)C1=CC=CC=C1 CFRTULIKXDWFLG-AGMMIYIUSA-N 0.000 description 1
• 108010052502 palicourein Proteins 0.000 description 1
• 229940055729 papain Drugs 0.000 description 1
• 235000019834 papain Nutrition 0.000 description 1
• 230000004963 pathophysiological condition Effects 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
• 229940111202 pepsin Drugs 0.000 description 1
• 239000000816 peptidomimetic Substances 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 239000000546 pharmaceutical excipient Substances 0.000 description 1
• 230000000144 pharmacologic effect Effects 0.000 description 1
• 238000001050 pharmacotherapy Methods 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 238000013081 phylogenetic analysis Methods 0.000 description 1
• 230000004962 physiological condition Effects 0.000 description 1
• 239000006187 pill Substances 0.000 description 1
• 239000003726 plant lectin Substances 0.000 description 1
• 235000021118 plant-derived protein Nutrition 0.000 description 1
• 229920000728 polyester Polymers 0.000 description 1
• 238000006116 polymerization reaction Methods 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 210000002729 polyribosome Anatomy 0.000 description 1
• 108010011723 polytryptophan Proteins 0.000 description 1
• 239000013641 positive control Substances 0.000 description 1
• 230000003389 potentiating effect Effects 0.000 description 1
• 238000001556 precipitation Methods 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 230000001681 protective effect Effects 0.000 description 1
• 238000000159 protein binding assay Methods 0.000 description 1
• 229960000856 protein c Drugs 0.000 description 1
• 230000004850 protein–protein interaction Effects 0.000 description 1
• 230000002797 proteolythic effect Effects 0.000 description 1
• 230000006337 proteolytic cleavage Effects 0.000 description 1
• 238000003908 quality control method Methods 0.000 description 1
• 230000002285 radioactive effect Effects 0.000 description 1
• 238000002708 random mutagenesis Methods 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 239000002265 redox agent Substances 0.000 description 1
• 238000002407 reforming Methods 0.000 description 1
• 230000024769 regulation of transport Effects 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 229940116190 repan Drugs 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000004044 response Effects 0.000 description 1
• PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
• ZTYNVDHJNRIRLL-FWZKYCSMSA-N rhodostomin Chemical compound C([C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(N[C@@H]2C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CSSC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H](CC=2NC=NC=2)C(O)=O)[C@@H](C)O)=O)CSSC[C@H]2C(=O)N[C@H]3CSSC[C@@H](C(NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H]2NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]4CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)CN)CSSC2)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N2CCC[C@H]2C(=O)N[C@H](C(N4)=O)CSSC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC3=O)C(=O)N[C@@H](CCCCN)C(=O)N1)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=CC=C1 ZTYNVDHJNRIRLL-FWZKYCSMSA-N 0.000 description 1
• 230000000630 rising effect Effects 0.000 description 1
• 210000003296 saliva Anatomy 0.000 description 1
• 239000012723 sample buffer Substances 0.000 description 1
• 238000003118 sandwich ELISA Methods 0.000 description 1
• 230000036186 satiety Effects 0.000 description 1
• 235000019627 satiety Nutrition 0.000 description 1
• 238000002821 scintillation proximity assay Methods 0.000 description 1
• 230000007017 scission Effects 0.000 description 1
• 238000010845 search algorithm Methods 0.000 description 1
• 238000002741 site-directed mutagenesis Methods 0.000 description 1
• 238000004513 sizing Methods 0.000 description 1
• 210000003491 skin Anatomy 0.000 description 1
• 238000011172 small scale experimental method Methods 0.000 description 1
• 239000012279 sodium borohydride Substances 0.000 description 1
• 229910000033 sodium borohydride Inorganic materials 0.000 description 1
• 238000001228 spectrum Methods 0.000 description 1
• 210000004215 spore Anatomy 0.000 description 1
• 235000020354 squash Nutrition 0.000 description 1
• 238000010561 standard procedure Methods 0.000 description 1
• 239000008174 sterile solution Substances 0.000 description 1
• 230000000638 stimulation Effects 0.000 description 1
• 210000002784 stomach Anatomy 0.000 description 1
• 238000010254 subcutaneous injection Methods 0.000 description 1
• 239000007929 subcutaneous injection Substances 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 235000000346 sugar Nutrition 0.000 description 1
• 150000008163 sugars Chemical class 0.000 description 1
• YZMCKZRAOLZXAZ-UHFFFAOYSA-N sulfisomidine Chemical compound CC1=NC(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 YZMCKZRAOLZXAZ-UHFFFAOYSA-N 0.000 description 1
• 239000000829 suppository Substances 0.000 description 1
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 239000003826 tablet Substances 0.000 description 1
• 238000004885 tandem mass spectrometry Methods 0.000 description 1
• 230000002123 temporal effect Effects 0.000 description 1
• 229940124597 therapeutic agent Drugs 0.000 description 1
• 238000002560 therapeutic procedure Methods 0.000 description 1
• 108060008226 thioredoxin Proteins 0.000 description 1
• 229940094937 thioredoxin Drugs 0.000 description 1
• 229960004072 thrombin Drugs 0.000 description 1
• 229960000187 tissue plasminogen activator Drugs 0.000 description 1
• 238000004448 titration Methods 0.000 description 1
• 239000012581 transferrin Substances 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• 230000009261 transgenic effect Effects 0.000 description 1
• 230000014621 translational initiation Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 210000004881 tumor cell Anatomy 0.000 description 1
• 108010072415 tumor necrosis factor precursor Proteins 0.000 description 1
• 241000712461 unidentified influenza virus Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 229960005356 urokinase Drugs 0.000 description 1
• 238000002255 vaccination Methods 0.000 description 1
• 208000007089 vaccinia Diseases 0.000 description 1
• 230000002792 vascular Effects 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 239000003981 vehicle Substances 0.000 description 1
• 108010047303 von Willebrand Factor Proteins 0.000 description 1
• 102100036537 von Willebrand factor Human genes 0.000 description 1
• 238000001262 western blot Methods 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 150000003952 β-lactams Chemical class 0.000 description 1